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ABSTRACT
Shoulder pain is a common complaint of diabetic patients that causes motion limitations and
functional disability. Adhesive capsulitis (AC) is the most common disabling shoulder
disorder. There is no optimal non-surgical treatment for managing AC in patients with diabetes.
Furthermore, the impact of diabetes on shoulder recovery and factors predicting shoulder
function following shoulder arthroplasty is not well investigated.
Purpose and Methods
The main purpose of this thesis was to inform clinical practice about the best intervention for
managing AC in diabetic patients, and to assess the impact of diabetes on functional outcomes
after shoulder arthroplasty, with the following objectives: 1) To systematically review clinical
research evaluating nonsurgical interventions for managing AC in diabetic patients; 2) To pilot
test study procedures and estimating the effects of incorporating a progressive walking program
as an adjunct to a regular physiotherapy program for managing AC in diabetic patients; 3) To
examine the effect of diabetes on shoulder function and physical health status; And 4) To
determine factors that predict shoulder functional outcomes following shoulder arthroplasty.
Results
Eight randomized trials (RCTs) were evaluated in a systematic review. The largest effect size
(2.0) was reported for joint mobilization plus exercises. The pilot RCT (n = 8) found that
regular physiotherapy (PT) group and regular physiotherapy program plus progressive walking
group (PT+) may improve functional performance and other outcomes, with a mean change of
PT = 3817, and PT+ = 633 seconds for Functional Impairment Test-Hand and
Neck/Shoulder/Arm (FIT-HaNSA) test from baseline to six weeks follow-up. A sample size of
89 participants per group is needed for future studies. Diabetic and non-diabetic patients
showed significant improvements in function and physical health status following shoulder
arthroplasty with no significant differences between groups. At one year after arthroplasty,
residual pain significantly predicted poorer shoulder function.
Conclusions
We found that low-quality evidence suggested large effects of joint mobilization plus exercises
on AC in people with diabetes. The pilot trial established that conducting a large-scale study
to assess the effect of the physiotherapy program for managing AC is feasible. Patients with
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and without diabetes may get equal surgical benefits, and residual pain may cause limitations
in shoulder function one year after arthroplasty.

Keywords
Adhesive capsulitis, Diabetes, Physical Therapy, Pilot trial, Shoulder arthroplasty, Systematic
review.
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LAY ABSTRACT
Frozen Shoulder is a common problem that occurs five times more frequently in patients with
diabetes. Frozen Shoulder causes pain and disability. The usual treatments reduce shoulder
pain and disability, but these treatments often fail for people with diabetes. Currently, we are
not sure what is the best treatment to manage Frozen Shoulder in patients with diabetes. We do
not know how diabetes can affect recovery after shoulder replacement surgery. Also, we are
not sure what factors can affect function after shoulder replacement surgery.
This thesis includes five papers. The first paper aimed at reviewing the literature of diabetic
shoulder. The second paper evaluated the effect of different conservative treatments that reduce
pain and disability in patients who have Frozen Shoulder. The third paper tests whether adding
a walking program to the usual care will result in better pain relief, motion and function. The
fourth paper assesses if diabetes impacts recovery after shoulder replacement surgery. The fifth
paper aimed to find factors that might affect shoulder joint function after replacement surgery.
Results show that exercises and steroid injections may improve shoulder pain and function in
patients with diabetes who have Frozen Shoulder. We think it is also possible to conduct a large
study to assess if adding a walking program to shoulder exercises would better improve
shoulder function in patients with Frozen Shoulders. We found that diabetes does not affect
recovery after shoulder replacement surgery. We also found that the presence of pain at one
year after surgery may cause shoulder disability.
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CHAPTER 1

THE DIABETIC SHOULDER- A LITERATURE REVIEW
A form of this manuscript is published in the Journal of Diabetes and Clinical Research

Citation:
Alsubheen SA, MacDermid JC, Overend TJ, Faber KJ. (2019). The diabetic shoulder – A
literature review. Journal of Diabetes and Clinical Research, 1(2),59-70.
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Abstract
Shoulder pain is one of the most common complaints of patients with diabetes that causes
motion limitation, functional disability and decreased quality of life. There is a higher
prevalence of shoulder disorders in patients with diabetes, with adhesive capsulitis (AC) and
rotator cuff (RC) tendinopathy being the most common disabling shoulder disorders. The
pathophysiology that predisposes patients with diabetes for the development of AC or RC
tendinopathy is not well-understood. However, the increased glycosylation of collagen fibers
of the joint capsule, tendons and ligaments, and the diabetic microangiopathy might potentially
explain the pathological process. Although some therapeutic interventions have been shown to
be effective in managing shoulder disorders, several studies have reported higher shoulder pain,
reduced mobility, poor functional outcomes, and a diminished response to treatment in patients
with diabetes than patients without diabetes. In the current literature, there is a lack of studies
on the best treatment approach for managing shoulder disorders in patients with diabetes.
Furthermore, the effect of diabetes on shoulder function after shoulder arthroplasty is not well
investigated. Future research is required to examine the effectiveness of different surgical and
non-surgical interventions on managing shoulder disorders in patients with diabetes. In
addition, more research is required to investigate the impact of diabetes on shoulder recovery
and factors predicting shoulder function following shoulder arthroplasty.
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1.1 Introduction to the thesis
1.1.1 Functional anatomy of the shoulder complex
The shoulder complex is composed of three bony structures: the clavicle, scapula, and humerus,
which are connected to form three synovial (glenohumeral, acromioclavicular, and
sternoclavicular) and two functional (scapulothoracic and subacromial) joints

[1]

. These

articulations link the upper extremity to the thorax and allow for great mobility of the arm. As
a result, the hand can be placed and moved through a large volume of space [2].
The combined mechanics of the articular joints and the surrounding soft tissue structures
(muscles, capsules, and ligaments) interact to provide mobility and stability of the shoulder
complex. In a normally functioning shoulder complex, both static and dynamic stabilizers
result in a broad range of joint movements and provide adequate stability. However, the unique
design of the shoulder complex that provides mobility with reduced stability also makes it
highly susceptible to dysfunction and injury [1,2].
1.1.1.1 Glenohumeral joint (shoulder joint)
The glenohumeral joint is a triaxial joint that connects the head of the humerus with the glenoid
fossa of the scapula. This joint has greater mobility than any other joint in the body

[1]

. Only

25% to 30% of the humeral head contacts the glenoid fossa at any given time. This anatomical
configuration results in an extensive joint mobility but low stability [2]. However, the interplay
between the static (capsule, labrum, ligaments) and the dynamic (muscle) forces provide a
precise constraint of the center of rotation through a large arc of motion [3].
The glenoid labrum deepens the fossa to provide additional stability and serves as the
attachment site for the joint capsule. The joint capsule along with the glenohumeral and
coracohumeral ligaments tighten to limit joint translation and provide static stability to the
shoulder. Further static stability is provided through the adhesive and cohesive forces of the
synovial fluid and the negative joint pressure that hold joint surfaces together [1,2].
During arm elevation, the dynamic stability of the glenohumeral joint is provided mainly by
the muscular forces of the rotator cuff and the deltoid. The rotator cuff consists of the
subscapularis, supraspinatus, infraspinatus and teres minor muscles. This group of muscles
inserts onto the facets of the greater and lesser tuberosities and provides a continual ring shaped
insertion from posterior-inferior to anterior-inferior on the proximal humerus

[2]

. The

contraction of the supraspinatus, along with the deltoid, causes arm elevation. The contraction
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of the infraspinatus and the teres minor muscles provides an external rotation force while the
internal rotation force results from the contraction of the subscapularis muscle [1].
The co-contraction of the rotator cuff produces a concavity-compression effect directed toward
the glenoid center to promote glenohumeral joint stability, while asymmetric contraction
causes humeral head rotation (steering mechanism) and depression during shoulder abduction
motion. However, due to the small size of the rotator cuff and its proximity to the joint center
of rotation, they generate lower muscle forces when compared to the larger and more
superficial muscles (deltoid, latissimus dorsi, trapezius, and pectoralis major) [2].
The long head of the biceps muscle plays a role in stabilizing the head of the humerus. Along
with the rotator cuff, it functions to depress the humeral head during shoulder abduction. In
addition, the contraction of the long head of biceps during the late phase of throwing reduces
anterior translation and resists external rotation [4]. Further static stabilization is promoted by
the tension placed on the static restraints and the glenohumeral ligaments that limit excessive
translations of humeral head [1].
1.1.1.2 Acromioclavicular and sternoclavicular joints
The acromioclavicular and the sternoclavicular joints are triaxial joints that connect the clavicle
to the acromion process of the scapula and the sternum, respectively. The stability of the
acromioclavicular joint is maintained through static stabilizers composed of a thick capsule, an
intra-articular disc, and the coracoclavicular ligament. The acromioclavicular ligaments
restraint the posterior translation of the acromioclavicular joint, while the coracoclavicular
ligaments restraint the vertical displacement of the joint [5].
The small sternoclavicular joint is the only joint that connects the shoulder complex to the axial
skeleton. The stability of the sternoclavicular joint is provided by the surrounding ligaments
composed of the intra-articular disc-ligament, costoclavicular ligament and interclavicular
ligament which act as a checkrein against medial displacement, excessive upward rotation and
excessive downward rotation of the clavicle, respectively [1,2].
1.1.1.3 Scapulothoracic articulation and muscles
The scapulothoracic articulation is a functional joint (not a true joint) that represents a space
between the thoracic cage and the anterior scapula. There is considerable soft tissue flexibility
that allows a relatively smooth slide of the scapula along the underlying thorax. The
scapulothoracic articulation synchronizes with the glenohumeral joint and allows for 150° to
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180° of shoulder range of motion (ROM) into flexion or abduction with elevation. For every
2° of glenohumeral elevation, there is 1° of scapulothoracic elevation. However, this ratio can
vary among individuals and for any part of the arc of movement [1,2].
Several muscles that originate from or insert into the scapula provide motion and dynamically
stabilize the scapula. In the dependent position, the scapula is maintained in downward rotation,
forward tilting, and protraction position. This position is stabilized by the balanced forces of
the trapezius, serratus anterior, levator scapula, and rhomboids musculature. The dependent
position of the scapula is further maintained by the static stabilization of the cohesive forces of
the subscapular bursa, acromioclavicular and sternoclavicular joint ligaments, and the
scapulothoracic facia [1,2].
During active arm motion, the scapulohumeral muscles maintain an effective length-tension
relationship and function to stabilize and control the position of the scapula, allowing a smooth
movement of the humerus. The serratus anterior maintains the medial angle of the scapula
against the chest wall and along with the upper and medial trapezius, upwardly rotates the
scapula during arm elevation [1,2].
During flexion and pushing activities, the serratus anterior muscle protracts the scapula on the
thorax. However, during arm extension or pulling activities, the rhomboids retract the scapula
and cause downward rotation while the latissimus dorsi, teres major, and rotator cuff muscles
function to exert rotational forces that cause the inferior scapula to move away from the midline
(upward rotation). In addition, these muscles eccentrically contract to control the upward
rotation and protraction of the scapula. The levator scapula elevates the superior angle,
resulting in upward and medial rotation of the scapula, while the pectoralis minor protracts and
rotates the scapula inferiorly [1,2].
1.1.2 Common musculoskeletal disorders of the shoulder joint
Musculoskeletal disorders affecting shoulder joint can either lead to hypomobility (restricted
mobility) or hypermobility (excess mobility) of the joint. Common pathologies that limit
shoulder movements include arthritis [rheumatoid arthritis (RA) or osteoarthritis (OA)],
adhesive capsulitis (AC)/frozen shoulder, and rotator cuff tendinopathy (RC)/impingement
syndrome [1].
Hypermobility of the shoulder joint causes joint instability and can be atraumatic or traumatic.
Atraumatic joint hypermobility can be due to an inherent generalized connective tissue laxity
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or secondary to repeated microtrauma. However, traumatic instability is usually caused by high
direct or indirect applied forces to the shoulder joint that often lead to joint dislocation
(complete separation of the articular surfaces) and soft tissue damage. Further, inherent
instability may be a pre-disposing factor to traumatic dislocation, especially with repetitive
stressful overhead activities. A secondary effect of joint hypermobility is painful shoulder
syndrome [1].
1.1.2.1 Shoulder arthritis
Arthritis can be defined as joint pain or joint disease. It can affect people of all ages, genders,
and races. Overtime, arthritis can lead to impaired mobility and functional limitations. Many
types of arthritis may affect shoulder joint including:
•

Osteoarthritis: is a chronic degenerative disorder affecting the articular cartilage of
shoulder joint leading to pain and stiffness. With degeneration, the capsule also
becomes thickened causing further loss of rotational movements. Shoulder OA is not
as common as OA of the knee or hip, however, it is reported to affect 32.8% of patients
over the age of 60 years [6]. The etiology of the primary shoulder OA is unknown but is
related to age (over the age of 65), genetics and sex; women are affected more
frequently than men. Secondary OA may occur as a result of repeated micro or high
impact trauma, chronic dislocation, or infection [6,7].

•

Rheumatoid arthritis: is an autoimmune, chronic, progressive inflammatory,
systematic disorder primarily affecting the synovial joint capsule and connective tissue.
Shoulder RA results in pain, loss of ROM, stiffness, progressive deformity and
functional disability [1,8]. The prevalence of shoulder RA is 1% worldwide and presents
in about 5% of people over the age of 70 years. It affects women more frequently than
men with a ratio of 3:1. Shoulder symptoms develop in about 91% of patients with
long-standing RA (more than 5 years) [8].

•

Post-traumatic/ immobilization arthritis occurs in response to an injury or fracture
to the shoulder; or from lack of movement, which causes rapid destruction of articular
cartilage. Immobilization arthritis could also occur as a secondary effect of medical
conditions such as stroke, diabetes, or heart disease [1].

1.1.2.2 Rotator cuff tendinopathy/impingement syndrome
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Rotator cuff tendinopathy is a progressive disorder of the rotator cuff tendons. The condition
begins with acute tendinitis of the muscle tendon (mainly the supraspinatus) and progresses to
tendinosis with degeneration and partial thickness tears. The condition may result in a full
thickness rupture. Rotator cuff tendinopathy causes pain in the shoulder region, leading to a
restricted and painful arc of motion, sleep disturbance, and shoulder dysfunction [1,9].
The etiology of RC tendinopathy is often multifactorial, and the symptoms are usually brought
on by repetitive or excessive overhead activities. Both intrinsic and extrinsic mechanisms play
a role in the pathology development and progression. Extrinsic factors are defined as those
causing narrowing of the subacromial space during arm elevation, leading to mechanical
compression/impingement and irritation of the soft tissues (rotator cuff and subacromial bursa).
Extrinsic factors could be anatomical, such as the shape and angle of the acromion, or
biomechanical (postural and muscular impairments) or a combination of both. The extrinsic
mechanism was first described by Codman (1934) and the concept was popularized by Neer in
the 1980s who coined the term subacromial impingement syndrome [9,10].
On the other hand, intrinsic factors affect the structural integrity of the musculotendinous
structures, leading to RC tendon degeneration. These factors include vascular changes in the
RC tendons, tissue tension overload, and collagen disorientation and degeneration. The
condition is observed most often in patients over 40 years old and disease prevalence increases
with age and can affect more than 50% of the population greater than 60 years old [1,9].
1.1.2.3 Adhesive capsulitis/ frozen shoulder
Adhesive capsulitis (AC), also known as ‘frozen shoulder’, is characterized by the development
of dense adhesions and capsular thickening leading to a progressive and painful restriction of
shoulder ROM and functional disability [11]. The condition does not cause arthritic changes in
the joint cartilage and bone as seen with OA and RA. The onset is gradual and usually occurs
between the ages of 40 and 65 years [1]. Further, it is five times more common in people with
diabetes and is more frequent in women [12].
Codman (1934) was the first to describe the condition, coin the term ‘frozen shoulder’ and
define the common criteria shared by most frozen shoulder patients which include slow onset
of pain, inability to sleep on the affected side, painful and restricted shoulder abduction and
external rotation motions, and normal radiographs [13].
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The frozen shoulder was termed shoulder adhesive capsulitis by Neviaser (1945) who found
thickening and contracture of the joint capsule and described peeling the capsule from humeral
head as peeling adhesive plaster from skin. In 1969, Lundberg suggested to subdivide frozen
shoulder, based on Codman criteria, into two groups: primary or idiopathic frozen shoulder,
which has no clear underlying cause, and secondary frozen shoulder, in which the condition is
secondary to soft tissue injury, OA, RA, trauma, or secondary to a known systemic disease
such as diabetes [13].
For many years, AC has been described as a self-limiting condition that progresses through a
natural history of painful, frozen and thawing phases, leading to full recovery without
treatment. However, a recent systematic review assessed the quality of the evidence that
describes the theory of AC phases and the theory of full recovery without treatment

[14]

. The

authors reported a lack of evidence to support the theoretical phases of AC. In addition, this
review found that moderate-quality evidence supported an early improvement in shoulder
ROM and function that slows over time and leads to long-term limitations [14].
The pathophysiology of idiopathic AC was studied in a recent systematic review that included
13 observational studies. There was consistent agreement among studies that the pathological
changes in the anterior shoulder joint capsule originated from the subscapularis bursa, at the
base of the origin of the long head of the biceps (rotator interval)

[15]

. These pathological

changes were described as a proliferation of fibroblasts arranged alongside layers of dense
collagen tissue, leading to capsular contracture. This fibrous tissue was noted to become tight
if the arm was placed in external rotation, forming a checkrein to further movement (the
presence of pathological fibrous tissue prevents full joint motion). The systematic review
suggested that fibrotic changes were associated with primary frozen shoulder [15].
Mechano-transduction is another potential mechanism that might trigger the development of
AC. Mechano-transduction refers to the mechanism by which cells convert external mechanical
stimuli or force into a set of biochemical reactions that elicit adaptive responses including
positional location and adhesion, contractile activation, responsiveness to shear stress and
growth

[16]

. Mechanical loading induces hypertrophy and strengthening of skeletal muscles,

tendons, ligaments and bones and have been long been implicated in regulating many
physiologic and pathologic processes. Even when forces are not externally applied, cells
experience endogenous mechanical forces that are generated by their internal cytoskeletal

8

machinery. Such cell-generated forces appear to alter many basic cellular functions, such as
cell proliferation, differentiation, sorting and migration [16].
Tissue samples from patients with AC demonstrated a dense collagen matrix and excessive
proliferation of fibroblasts and contractile myofibroblasts at the anterior part of the joint
capsule

[15]

. The increase in collagen cross-linking and density lead to the development of

fibrous tissue which alters the mechanical properties of the extracellular matrix of articular
capsule, ligaments and muscle-tendon units by making tissue stiffer and weaker [16,17].
Research investigating the mechano-transduction mechanism demonstrated that the presence
of external and internal loading might alter numerous cellular functions including migration,
prefiltration and differentiation, making tissue stiffer and weaker

[16]

. However, these studies

were inconclusive about AC pathophysiology and no study directly linked AC to the mechanotransduction mechanism.

1.1.3 Association between diabetes and shoulder disorders
Diabetes is a metabolic condition that is characterized by persistent hyperglycemia due to
insulin deficiency, impaired effectiveness of insulin action, or both. Diabetes is considered one
of the most challenging health problems in the 21st century. It is one of the most disabling
diseases and the fifth leading cause of death in most developed countries [18,19].
Based on the etiology, diabetes can be classified into two main types: type 1 diabetes, which
results from cell-mediated autoimmune destruction of pancreatic islet beta cells causing the
loss of insulin production; and type 2 diabetes, which occurs due to insulin deficiency and/or
insulin resistance. However, other types of diabetes do exist such as gestational diabetes
(occurs during pregnancy), type 3 diabetes (resistance to insulin in the brain), secondary
diabetes (as a consequence of other medical condition), neonatal diabetes (affects babies under
6 months old), and many others [18].
Type 1 diabetes occurs more commonly in children, while type 2 diabetes is seen more
frequently among adults and constitutes about 85% to 95% of all diabetes in developed
countries. Diabetes can be found in almost every population in the world. The global burden
of diabetes is estimated to be 10.4% for persons aged 20-79 years by the year 2040. In Canada,
it is predicted that there will be a large increase in the number of people with diabetes from 9%
in 2003 to 11.2% in 2025. In addition, the prevalence of diabetes is more than four times higher
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among First Nations women than non-First Nations women and more than 2.5 times higher
among First Nations men as compared to non-First Nations men

[18–20]

Diabetes has many well-described complications including neuropathy, cardiovascular
diseases, retinopathy, stroke, peripheral vascular disease (amputation), and renal failure that
result in disability, reduced life span, and increased health cost

[18]

. Complications involving

the musculoskeletal system are generally less well-described. Shoulder pain is one of the most
common complaints of patients with diabetes that causes motion limitation, functional
disability and decreased quality of life. There is higher prevalence of shoulder disorders in
patients with diabetes, with AC and RC tendinopathy being the most common disabling
shoulder disorders [11,12].
The association between diabetes and AC was first recognized by Bridgman (1972) who found
that 10.8% of patients with diabetes had AC as compared to 2.3% patients without diabetes [21].
Subsequent studies have supported this association and reported a prevalence of AC in 10-76%
type 1 and 7-30% type 2 diabetes as compared to 0-10% in the general population

[22–25]

Adhesive capsulitis was also reported to be associated with age in both types of diabetes

.

[22]

and with the duration in type 1 diabetes [23,24,26].
Patients with diabetes, with or without the use of insulin, have a high risk for developing RC
tendinopathy, with a hazard ratio (HR) of 2.11 as compared with those without diabetes [11]. In
addition, chronic RC tendinopathy and shoulder pain have been associated with diabetes

[27]

.

Further, patients with diabetes have been reported to have a concurrent diagnosis of AC and
RC tendinopathy, leading to shoulder pain and contracture [28]. Furthermore, diabetes has been
associated with postoperative stiffness after rotator cuff repair [28,29].
The pathophysiology that predisposes patients with diabetes for the development of AC or RC
disease is not well-understood. However, the two diseases might share similar diabetes-related
mechanisms

[11]

. Indeed, several potential mechanisms have been suggested that explain the

pathological process including the increased glycosylation of collagen fibers of the joint
capsule and the diabetic microangiopathy [11,17,30].
Collagen is the main structural protein in the extracellular matrix in the various connective
tissue in the body. Normally, collagen fibers are glycosylated meaning that collagen protein
molecules have sugar molecules covalently bonded to them through a specific enzymatic
process. However, in diabetic tissue, hyperglycemia can cause a non-enzymatic covalent
bonding of sugar molecules to the collagen fibers. Over time, the glycating sugar reacts further
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leading to the abnormal biochemical formation of pathological collagen tissue known as
advanced glycation end-products (AGEs). These AGEs increase crosslinking in the collagen
fibers of shoulder capsule, tendons and ligaments, making making these structures stiffer and
weaker

[11,17,30,31]

. The cross-linking collagen accumulate in the shoulder capsule leading to

joint stiffness and chronic inflammatory process in the synovium

[11]

. In addition, an increase

in cell proliferation and cellularity of fibroblasts may result in dense layers of collagen tissue,
leading to capsular contracture [11,30,31].
Further, arthroscopic biopsies of joint synovium in patients with diabetes showed greater
amounts of endothelial growth factors and reduced amounts of inflammatory growth factors.
These findings explained the prolonged course and severity of AC in patients with diabetes [31].
However, other studies reported that AGEs interact with the receptors on the surface of
tenocytes and fibroblasts, leading to chronic inflammatory changes in the joint synovium,
which contribute to capsular fibrosis of the shoulder joint [11,30].
The impaired microcirculation (diabetic microangiopathy) is another pathological process that
may contribute to the development of AC and RC tendinopathy in patients with diabetes. There
is a consensus among studies that uncontrolled hyperglycemia leads to macrovascular and
microvascular complications in patients with diabetes [11,30].
It is documented that AGEs are prevalent in the diabetic vasculature and contribute to the
development of atherosclerosis. AGE cross-linking of collagen fibers in the basement
membrane of the extracellular matrix leads to thickening of the basement membrane, stiffness
of blood vessels and alterations in vascular contractility. As a result, tissue hypoxia occurs
causing joint tissue destruction and degenerative changes

[11,30]

. Moreover, AGEs induce

vascular endothelial growth factor which causes synovial cell proliferation in the subacromial
bursa synovium, leading to the development of shoulder joint contracture in patients with
diabetes who have AC and RC tendinopathy [29].
1.1.4 Assessment of shoulder joint
The assessment of the shoulder joint is essential for the diagnosis and formulation of an
appropriate management for patients with shoulder disorders. The assessment usually starts
with obtaining a detailed history about patient's demographics, medical history, and the onset
of the condition symptoms, followed by inspection and palpation. The assessor inspects
shoulders for symmetry and deformity and palpates joints for any tenderness, swelling, or
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anatomic abnormalities. It is also essential to examine the neck area to rule out cervical spine
pathology and referred neck pain [32,33].
One of the next steps in diagnosing shoulder pathology is to measure shoulder active and
passive ROM including forward flexion, abduction, external and internal rotation. The
assessment of shoulder ROM can be performed by visual estimation or by using goniometer.
Goniometric measurements are extensively used in physical therapy for measuring any joint
motion in degrees. Measuring shoulder joint active and passive ROM can provide useful
information in differentiating some shoulder disorders such as AC and RC tendinopathy. For
example, AC is reported to be associated with limitation in both active and passive ROM, while
RC tendinopathy is usually associated with limitations in only active ROM [33].
Several clinical special and strength tests are often used to diagnose shoulder pathology.
However, one test is not interpreted in isolation but is clustered with additional clinical findings
when establishing a clear diagnosis for shoulder problems. Examples of these tests include
Hawkins' test and Neer's sign to help in diagnosing shoulder impingement syndromes; Droparm test, Lift-off test and Empty Can test are strength tests that indicate a defect in the RC;
Apprehension and Relocation tests to diagnose anterior shoulder instability; and Yergason's
test and Speed's maneuver to assist in the diagnosis of biceps tendon instability or tendonitis
[32,33]

.

Several self- and examiner-reported outcome measures tools have been validated to assist in
the examination of shoulder pain and function. These measures include the Visual Analogue
Scale (VAS) for pain assessment, and measures of shoulder function and disability such as the
Shoulder Pain and Disability Index (SPADI), Constant Shoulder Score (CSS), American
Shoulder and Elbow Surgeons (ASES), Disabilities of the Arm, Shoulder, and Hand (DASH;
Quick DASH), and Simple Shoulder Test (SST) questionnaires. All of these questionnaires
have been shown to be valid and reliable for the assessment of shoulder function in various
clinical situations [34].
Lastly, there are several imaging tests to confirm the diagnosis of shoulder joint pathology
including plain x-ray to diagnose bone abnormalities such as osteoarthritis, ultrasound which
may be used to diagnose rotator cuff pathology, and magnetic resonance imaging (MRI) and
computerized tomography scan (CT), which are used to diagnose bone and soft tissue
abnormalities [32].
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1.1.5 Management of shoulder disorders
As mentioned earlier, obtaining a complete patient history and performing a thorough physical
examination are essential in determining proper means of treatment for different shoulder
disorders. Several studies have examined the effectiveness of surgical and non-surgical
treatment interventions for managing shoulder disorders such as AC, RC tendinopathy,
arthritis,

and

shoulder

instability.

The

non-surgical

interventions

may

include

physiotherapeutic interventions, pain-control medications, and steroid injection. Examples of
surgical approaches include shoulder arthroscopy and shoulder arthroplasty.
1.1.5.1 Non-surgical interventions
The most common shoulder disorders that might be treated by non-surgical interventions are
AC, RC tendinopathy, mild to moderate shoulder OA, and shoulder instability. It is generally
recommended to start with a non-surgical treatment for managing these disorders when pain
and functional limitation are modest. Surgical interventions may be considered for patients
who remain functionally disabled in spite of appropriate non-surgical treatment [33,35].
Physical therapy interventions have been shown to benefit patients with different shoulder
conditions. For example, low-level laser therapy was found to reduce pain and improve
function in patients with AC

[36]

. In addition, deep and superficial heat modalities have been

reported to provide short-term pain relief and improve ROM for patients with AC; however,
the use of US for reduce pain and improve function is not recommended

[36]

. Active ROM

exercises, self-stretching and joint mobilization techniques have been reported by several
systematic reviews to reduce pain and restore shoulder ROM and function in patients with AC
[36–39]

. Further, gentle ROM and isometric strengthening of the rotator cuff and scapulothoracic

muscles are effective in reducing pain and improving shoulder ROM in patients with mild to
moderate shoulder OA with no evidence of atrophy or contracture [6].
Physical therapy programs that emphasize progressive strengthening of the rotator cuff,
deltoid, and scapulothoracic muscles combined with functional exercises that require
coordination among multiple muscle groups have been commonly recommended for treating
patients with shoulder instability. These exercises are reported to control glenohumeral joint
translation, improve shoulder joint stability, and reduce anterior glenohumeral ligamentous
strain especially during arm elevation [40]. In addition, for post-traumatic shoulder instability,
a weak evidence supports the use of ROM and strengthening exercises [35].
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The effectiveness of exercise therapy for the treatment of RC tendinopathy/impingement has
been investigated in several systematic reviews [41–44]. Data from these reviews strongly suggest
that therapeutic exercises combined with manual therapy produce statistically and clinically
significant reductions in pain and improvement in shoulder ROM. In addition, exercise therapy
may be effective at improving shoulder function. This effect may be augmented with
acromioplasty and joint mobilization techniques [41–44]. However, a moderate-quality evidence
(on GRADE scale) indicates that subacromial decompression provides no improvement in
shoulder pain and function for the treatment of RC tendinopathy [45].
A typical physical therapy program may include pendulum exercise, active assisted and active
ROM exercises, postural exercises, scapular stabilization exercises, stretching exercises, joint
mobilization techniques, and soft tissue mobilization techniques. However, none of these
systematic reviews described the specific components of the exercise protocols (type, intensity,
duration and frequency) that are associated with best outcomes [41–44].
Intra-articular steroid injections are commonly used for patients with shoulder pain. There is
moderate evidence that supports small short-term pain reduction in patients with AC following
steroid injection [36–38,46]. Further, steroid injections provide superior improvements in shoulder
pain for patients with RC impingement when compared to no injection controls, and ultrasound
guided injections are superior to non-guided injections

[41]

. Furthermore, corticosteroid

injections seem to relieve shoulder pain in patients with shoulder OA [6,47].
1.1.5.2 Surgical interventions
In patients with persistent shoulder pain and dysfunction despite conservative treatments,
surgery may be indicated to relieve pain and restore joint function. A number of different
surgical approaches to manage shoulder disorders have been reported in the orthopedic
literature including shoulder arthroscopy and shoulder arthroplasty.
Shoulder arthroscopy is performed by inserting an arthroscope into the joint through a small
incision. This minimally invasive surgical procedure allows for an examination and treatment
of various joint pathologies. For patients with AC, a diagnostic arthroscopy is performed to
confirm the diagnosis followed by release and excision of fibrotic structures such as the rotator
interval, the middle glenohumeral ligament and the axillary pouch. Two systemic reviews have
reported that this procedure improves shoulder ROM and function and is an effective treatment
for AC [46,48]. However, confidence in these findings is a concern due to poor methodological
quality of the included studies [46,48].
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Further, arthroscopic treatment of RC tendinopathy has been shown to significantly improve
shoulder symptoms and function treated using different arthroscopic approaches such as
debridement of the tear with or without acromioplasty, trans-tendon repair, or conversion of
the lesion to full thickness tear followed by repair [49].
Shoulder arthroplasty is a common surgical procedure in which all or part of the shoulder joint
is replaced by a prosthetic implant to alleviate shoulder pain and restore joint function

[50]

.

Shoulder arthroplasty, which was pioneered by Gluck and Péan in the 1800s to treat
tuberculous arthritis of the shoulder, failed miserably, and the procedure was eventually
revisited by Neer in the 1950s for the treatment of proximal humeral fractures. Recent
advancements in prosthesis design have resulted in expanded indications and a concomitant
increase in the rates for shoulder arthroplasty [51,52]
Currently, end-stage primary glenohumeral osteoarthritis is the primary diagnosis for 77% of
shoulder arthroplasty and often occurs more frequently among adults aged 65 years or older
[53]

. This surgical procedure is usually indicated when conservative treatments such as

therapeutic exercises and manual therapy techniques fail [53].
There are three main types of shoulder arthroplasty: total shoulder arthroplasty (TSA),
hemiarthroplasty (HA), and reverse total shoulder arthroplasty (rTSA). TSA involves replacing
both the humeral head and the glenoid fossa, while HA involves replacing only the humeral
head with metal implants. However, in rTSA, the surgeon replaces the anatomical humeral
head with a plastic socket and replaces the anatomical socket of the scapula with a metal ball.
Patients with OA and an intact or reparable rotator cuff typically undergo TSA, while patients
with OA and an irreparable rotator cuff tear traditionally undergo rTSA or HA [54]. However,
TSA has been reported to result in greater improvement in shoulder ROM and pain, and in less
need for surgery revision when compared to HA [51].
The main indication for rTSA is shoulder OA with irreparable rotator cuff tear when
conventional surgery fails. However, the advancement of the prosthetic design has led to
expansion of the indications to include any condition about the shoulder where rotator cuff
function is deficient including RA and proximal humeral fractures [55].
Despite the improvements of shoulder function and pain after shoulder arthroplasty, shoulder
arthroplasty is not without complications. Shoulder subluxation or dislocation, periprosthetic
fracture, and joint infection are the most commonly reported postoperative complications [50,56].
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Additional complications that are specific to rTSA may include glenoid loosening,
musculocutaneous nerve palsy, and acromial fractures [55].
1.1.6 Impact of diabetes on shoulder recovery
All the above-mentioned interventions have been evaluated in generic populations and have
been shown to be effective in reducing shoulder pain and improving ROM and function.
However, patients with shoulder disorders and concurrent comorbidities such as diabetes have
been reported to respond less favorably to these interventions. Indeed, a recent systematic
review evaluated the effectiveness of non-surgical interventions for managing AC in patients
with diabetes [57]. The authors reported that low quality evidence suggests large effects of joint
mobilization plus exercises on AC in people with diabetes and even weaker support was
available for corticosteroid and manipulation under anesthesia (MUA) [57].
Vastamaki et al. followed-up patients with and without diabetes who have AC for the duration
of 10 years. Although shoulder ROM improved over time in patients with diabetes, this
improvement was inferior to patients without diabetes and remained below normal ROM

[58]

.

Further, Juel et al. and Larkin et al. have also shown that patients with type 1 diabetes develop
long-lasting shoulder stiffness, functional disability and reduced ROM than patients without
diabetes. These studies suggested that early shoulder assessment and treatment may be needed
to reduce disability and improve quality of life of patients with diabetes

[23,24]

.

Furthermore, in longitudinal cohort studies, Rill et al. evaluated the effect of operative and
nonoperative treatments on AC using the SST questionnaire, while Cole et al. evaluated the
association between diabetes and shoulder complaints using the SPADI questionnaire. Both
studies reported higher shoulder pain, reduced mobility, poor functional outcomes, reduced
quality of life, and a diminished response to treatment in patients with diabetes who have AC
than patients without diabetes [59,60].
Studies that evaluated the impact of diabetes on shoulder recovery following arthroscopic
rotator cuff repair have reported an inferior improvement in shoulder pain and function in
patients with diabetes, in addition to an increased risk of anatomic failure of the repaired rotator
cuff tendon especially in patients with uncontrolled hyperglycemia [61,62].
Diabetes has been shown to be an independent risk factor for increased risk of non-home
discharge (Odds ratio (OR): 1.3), and longer hospital stays (OR: 1.4) following shoulder
arthroplasty [63,64]. Further, diabetes, along with hypertension and obesity, are associated with
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[65]

postoperative complications such as humeral fracture and joint infection

. However, the

impact of diabetes on functional outcomes and motion after shoulder arthroplasty has not yet
been investigated.
1.1.7 Summary of limitations in current knowledge
Studies consistently report that patients with diabetes are more frequently affected by AC, have
long lasting symptoms and a poorer prognosis than patients without diabetes [11,22–25,66]. Further,
although some of the therapeutic interventions have been shown to be effective in managing
primary AC, several studies have reported higher shoulder pain, reduced mobility, poor
functional outcomes, reduced quality of life, and a diminished response to treatment in patients
with diabetes than patients without diabetes

[23,24,59,60]

. There is lack of systematic reviews to

assess the effectiveness of therapeutic interventions in managing AC in patients with diabetes
and to show whether the current recommendations for treatment of AC can be equally applied
to patients with diabetes.
There have been efforts to define an optimal physical therapy protocol for managing AC in
patients with diabetes. The usual approach to AC includes mobilization of soft tissues and
implementation of shoulder exercises to restore function. However, recovery is slow and often
incomplete, especially for people with diabetes. Aerobic exercises can improve hyperglycemia
and insulin sensitivity in skeletal musculature [67], which may have a greater impact on the AC
pathophysiology. To the author's knowledge, an optimal physical therapy protocol for
managing AC in patients with diabetes is not defined.
Given the fact that hyperglycemia has a negative impact on body tissue
effect of diabetes on postoperative complications and hospital stays

[17]

, and the adverse

[63,65]

, there is a need to

investigate whether diabetes affects functional outcomes after shoulder arthroplasty. To the
author's knowledge, no study has evaluated the impact of diabetes on shoulder pain and
function following shoulder arthroplasty.
There are limited studies that have addressed the factors which influence postoperative
functional outcomes following shoulder arthroplasty. Identifying preoperative factors that are
predictive of one-year outcomes could assist surgeons and health care providers in providing
patients with more realistic expectations on outcomes and may help plan postoperative pain
management and rehabilitation. To the author's knowledge, factors that predict the clinical
benefits following shoulder arthroplasty have not been thoroughly investigated.
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1.1.8 Future directions
There is a need to conduct systematic reviews to determine the effectiveness of non-surgical
interventions (steroid injections, physiotherapeutic interventions, and MUA) and surgical
interventions (arthroscopy and arthroplasty) on shoulder pain, function, and ROM for
managing AC in people with diabetes. Further, clinical researchers need to run more robust
randomized trials to examine the impact of these therapeutic interventions on shoulder function
in patients with diabetes as compared to patients without diabetes. Furthermore, studies are
required to investigate the impact of diabetes on pain, patient-reported function, and
impairments in shoulder ROM and muscle strength in patients who underwent shoulder
arthroplasty. Lastly, further research is recommended to investigate whether factors such as
comorbidities and demographics predict patient-reported outcomes including shoulder pain
and function and clinical benefits following shoulder arthroplasty
In summary, studies to examine the effectiveness of different surgical and non-surgical
interventions on managing shoulder disorders in patients with diabetes are required. In
addition, more research is required to investigate the impact of diabetes on shoulder recovery,
and factors predicting shoulder function following shoulder arthroplasty.
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1.2 Purpose of this thesis
The two purposes of this thesis were to inform physical therapy management of 1) patients
with diabetes who have AC and 2) patients with diabetes who are recovering from shoulder
arthroplasty. We have the following objectives:
-

To conduct a systematic review that determine the effectiveness of non-surgical
interventions [steroid injections, physiotherapeutic interventions (joint mobilization,
laser therapy, continuous passive motion, electrotherapy, reflexology, therapeutic
exercises) and MUA] on shoulder pain, function, and ROM for managing AC in people
with diabetes.

-

To run a pilot randomized trial that compares the effect of a regular physiotherapy (PT)
program to a regular PT combined with a progressive walking program (PT+) in
patients with and without diabetes who have AC. This pilot trial will also evaluate the
feasibility of recruitment, randomization, retention, assessment procedures, and
implementation of the novel intervention. Data from this pilot trial will be used to
calculate an accurate sample size for a full-scale RCT. The secondary objective was to
determine if diabetes affects response to treatment.

-

To investigate the impact of diabetes on pain, patient-reported function, and
impairments in shoulder ROM and muscle strength in patients who underwent shoulder
arthroplasty.

-

To examine whether age, sex, diabetes, hypertension, and depression predict patientreported outcomes including shoulder pain and function one year following shoulder
arthroplasty; if these factors predict the clinical benefits following surgery as reflected
in the change of outcome scores; and if residual pain (pain at one-year) is associated
with poorer functional outcomes.

1.3 Overview of thesis chapters
This thesis focuses on understanding the impact of diabetes on shoulder disorders. This work
addresses a gap in the literature since remarkably few studies have focused on managing AC
and shoulder recovery after arthroplasty in patients with diabetes. This work is completed as a
manuscript thesis where following chapter one which reviews the relevant literature, a series
of inter-related manuscripts are presented in individual chapters.
In chapter 2, we have conducted a systematic review where we have reviewed the quality and
content of clinical research addressing the effectiveness of non-surgical interventions including
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physiotherapeutic interventions, steroid injections, and manipulation under anesthesia for
managing AC in patients with diabetes.
In chapter 3, we have included a pilot study which compared the effect of a regular
physiotherapy (PT) program to a regular PT combined with a progressive walking program
(PT+) in patients with and without diabetes who have AC.
Chapter 4 is a cohort study that evaluated the following research question: Does diabetes affect
functional outcomes after shoulder arthroplasty?
Chapter 5 is a cohort study that examined factors predicting shoulder function and clinical
benefits one-year following shoulder arthroplasty.
The final chapter provides a general discussion and formulated conclusions based upon the
previous research, including the most significant findings. We have also provided future
research directions and recommendations.
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Abstract
Objective: This systematic review evaluated the effectiveness of non-surgical interventions
for managing adhesive capsulitis (AC) in patients with diabetes on pain, function and range of
motion.
Data Sources: MEDLINE and other databases were searched for studies published in the last
20 years.
Study Selection: Randomized clinical trials (RCTs) that assessed adhesive capsulitis in people
with diabetes and implemented one or a combination of physiotherapeutic interventions,
corticosteroids, and manipulation under anesthesia (MUA) were eligible for inclusion.
Data Extraction: The Cochrane Risk of Bias was used by two independent raters who met to
achieve consensus. The quality of trials was assessed using Grading of Recommendations,
Assessment, Development and Evaluations (GRADE). Data extracted from the eligible studies
included study design, subject characteristics, duration of symptoms, type of intervention,
outcome measures, follow-up intervals and research findings.
Data Synthesis: Due to the lack of similar interventions, a narrative synthesis was conducted,
and meta-analyses were not performed. The effect sizes or between-group differences of the
interventions were reported. A total of eight RCTs met the inclusion criteria: four addressed
physiotherapeutic interventions, three corticosteroid injections and one MUA. The effect sizes
for physiotherapeutic interventions were 0.8-2.0, 0.9-2.0, and 1.0 for ROM, function and pain
respectively, with the largest effect size (2.0) being reported for joint mobilization plus
exercises. The effect sizes for corticosteroids were 0.2-0.5 and 0.1 for ROM and pain. The
between-group improvement for MUA was 5.6 points on Constant Shoulder Score.
Conclusion: Low quality evidence suggests large effects of joint mobilization plus exercises
on adhesive capsulitis in people with diabetes, although confidence in this conclusion is limited
due to at the high risk of bias. Even weaker support was available for corticosteroid and MUA.
Future high quality RCTs are needed to determine the best intervention for managing AC in
patients with diabetes.
Systematic

review

registration

#:

CRD42018084090

on

PROSPERO

(https://www.crd.york.ac.uk/PROSPERO)

Keywords: Adhesive capsulitis, Corticosteroids, Diabetes, Physiotherapy, Systematic review
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2.1 Background
2.1.1 Description of the condition
Adhesive capsulitis (AC), also known as frozen shoulder, is a common shoulder disorder that
is characterized by a progressive and painful restriction of range of motion (ROM), that results
in functional disability

[1]

. The condition is more common in people with diabetes with an

estimated prevalence of 10-76% in type 1 and 7-30% in type 2 diabetes as compared to 0-10%
in the general population

[2–5]

. Adhesive capsulitis is more frequent in women

[6]

and is

associated with age in both types of diabetes [5] and with the duration in type 1 diabetes [2,3,7].
Further, poor glycemic control has been shown to worsen shoulder pain and function in people
with type 1 diabetes [2,3].
Primary or idiopathic AC has no clear underlying cause and secondary AC is associated with
a known systematic cause such as diabetes. The pathophysiology of primary AC is poorly
understood but could occur as a result of inflammatory or fibrosing processes [8]. However, the
glycosylation of collagen fibers of the joint capsule and the impaired circulation of the joint
small capillaries have been proposed as potential mechanisms that might explain the
pathological process in patients with diabetes [1].
For many years, AC has been described as a self-limited condition that progresses through a
natural history of painful, frozen and thawing phases, leading to full recovery without
treatment. However, a recent systematic review assessed the quality of the evidence that has
characterizes AC into three phases and that supports the concept that full recovery occurs
without treatment [9]. The authors reported a lack of evidence to support the theortical phases
of AC. In addition, this review found that moderate-quality evidence supported an early
improvement in shoulder ROM and function that slows over time and leads to long-term
limitations which questions the common perception that AC is a self-limited condition. Further,
they reported that low-quality evidence suggested incomplete improvement in ROM after one
to four years of follow-up [9]. The authors recommended that the theory of natural progression
of AC should be removed from professional and public information sites since it is not
supported and potentially misleading. They also noted the need for future research towards
diagnostic processes to identify the underlying causes of stiffness and disability of patients
with AC [9].

2.1.2 Description of the therapeutic interventions
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The diagnostic criteria of AC such as the global loss of shoulder ROM and night pain have
been proposed by several experts

[10]

. However, these clinical criteria were not found to be

valid diagnostic signs of AC due to the lack of information about the first 3-6 months of this
disorder [9,10]. Thus, there is uncertainty about AC diagnosis and natural history

[9]

. The lack

of understanding of early AC suggests that appropriate early treatment might be needed to
avoid long-term functional limitations and disability [9].
Although studies

[11]

evaluating the supervised-neglect approach have shown to yield better

outcomes than passive mobilization and stretching in patients with AC, the improvement in the
supervised-neglect group cannot strictly be considered as the natural gentle thawing of the
condition because patients were instructed to do pendulum and active exercises within the
painless ROM which constitutes a home exercise program that is expected to provide
therapeutic benefits [11]. Furthermore, Diercks et al. excluded patients with diabetes from their
study because of concerns that the disorder behaved differently in this population subset

[11]

.

Therefore, the supervised-neglect approach may not be applicable for patients with diabetes.
Vastamaki et al. followed-up patients with and without diabetes who have AC for the duration
of 10 years

[12]

. Although shoulder ROM improved over time in patients with diabetes, the

improvement was inferior to patients without diabetes and remained below normal ROM

[12]

.

Other studies have also shown that patients with type 1 diabetes develop long-lasting shoulder
[2,3]

stiffness, functional disability and reduced ROM than patients without diabetes

. These

studies suggested the need to start early shoulder assessment and treatment to reduce disability
and improve quality of life of patients with diabetes

[2,3]

. Lastly, Wong et al. showed that

moderate to strong evidence supports early treatment interventions to reduce pain and improve
ROM and function compared to the low evidence that supports a “no treatment” approach [9].
Several systematic reviews have examined the effectiveness of different treatment approaches
for AC in generic populations, i.e. not specifically people with diabetes

[13–18]

. Moderate

evidence showed small short-term benefits of steroid injection in reducing pain [13,14,16,18], while
some physiotherapeutic interventions such as exercises and joint mobilization have been shown
to reduce pain, restore shoulder ROM and function in both short and long-term [13,14,16,17]. Low
to moderate evidence was found for the effectiveness of acupuncture on pain and ROM [14,16].
Furthermore, a recent randomized trial reported that acupuncture relieved pain and restored
shoulder function in patients with frozen shoulder

[19]

. Studies of MUA and surgical capsular

release that report clinical benefits unfortunately have poor methodological quality [15,18].
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2.1.3 Why it is important to conduct this systematic review?
Studies have consistently reported that people with diabetes are more frequently affected by
AC, have long lasting symptoms and a poor prognosis

[20]

. Further, although some of the

therapeutic interventions have been shown to be effective in managing primary AC, several
studies have reported higher shoulder pain, reduced mobility, poor functional outcomes,
reduced quality of life, and a diminished response to treatment in patients with diabetes than
patients without diabetes [2,3,12,21,22]. In addition, none of the aforementioned systematic reviews
focused on patients with diabetes, or formally tested diabetes as a source of clinical
heterogeneity in response to treatment. The underlying pathophysiology of AC in patients with
diabetes may differ from non-diabetics and it is unclear whether existing recommendations for
the treatment of AC can be equally applied to the subset of patients with diabetes.

2.2 Objectives
To determine the effectiveness of steroid injections, physiotherapeutic interventions (joint
mobilization, laser therapy, continuous passive motion, electrotherapy, reflexology,
therapeutic exercises) and MUA on shoulder pain, function, and ROM for managing adhesive
capsulitis in people with diabetes.

2.3 Methods
2.3.1 Study selection
2.3.1.1 Study design
Randomized controlled trials published in English or any other language were eligible for
inclusion in this review.

2.3.1.2 Participants
Trials that included adult participants aged 18 years or older with a stated diagnosis of AC and
diabetes (both types) were eligible to be included in this review. Due to lack of a gold standard
for the diagnosis of AC, trials were included if it was stated that participants had pain and
restriction in shoulder joint ROM in one or more planes [23]. Studies that included participants
with other shoulder disorders such as rotator cuff tendinitis or osteoarthritis were not eligible
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for inclusion. Further, studies that excluded patients with diabetes or included patients with
diabetes treated in one group with patients without diabetes were also excluded from this
review unless these studies' authors provided a subgroup analysis of patients with diabetes.

2.3.1.3 Types of interventions
Trials that randomly implemented one or a combination of the following non-surgical
interventions were eligible for inclusion in this review: physiotherapeutic interventions,
corticosteroid

injection,

MUA,

hydrodilatation,

and

suprascapular

nerve

block.

physiotherapeutic interventions could include, but were not limited to, mobilization techniques,
exercises, electrotherapy, and patient education.

2.3.1.4 Outcome measures
Studies that assessed at least one outcome measure that is validated and commonly used to
examine shoulder pain or function were eligible for inclusion. These measures could include
measures of shoulder pain using Visual Analogue Scale (VAS), measures of ROM using
standard or electronic goniometer, and measures of shoulder function and disability such as the
Shoulder Pain and Disability Index (SPADI), Constant Shoulder Score (CSS), American
Shoulder and Elbow surgeons (ASES) and Simple Shoulder Test (SST) questionnaires. All of
the questionnaires are valid and reliable to assess shoulder function in different clinical
situations [24]. However, only the SPADI has specifically been validated for patients with AC
[25,26]

.

2.3.2 Search methods for identification of studies
2.3.2.1 Electronic searches
To conduct this systematic review, an electronic search of the following databases was
performed: MEDLINE, Science Direct, Scopus, Cumulative Index to Nursing and Allied
Health Literature (CINAHL), Cochrane library, EMBASE, Ingenta connect, Sport Discus,
Physiotherapy Evidence Database (PEDro) and ProQuest. The search of these databases was
conducted on a university library system during the months of October 2017-January 2018.
The search was limited to human subjects and articles published within last 20 years. Diabetes
and the two most common terms used to describe the shoulder condition, "adhesive capsulitis"
and "frozen shoulder", were combined using the operation "AND" and were used as key terms
for the search. MEDLINE was searched using a combination of the key terms and the "AND"
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operation with the following terms: "physiotherapy", "exercise", "manual therapy", "joint
mobilization", "modalities", electrotherapy", rehabilitation", corticosteroids", "manipulation
under anesthesia", "arthroscopy", hydrodilatation", and "suprascapular nerve block". The
MEDLINE search strategy is illustrated in Box 1.

2.3.2.2 Searching other resources
Reference lists of all relevant articles were scanned in an attempt to identify any further studies.
We also searched common shoulder and diabetes journals' supplements to identify conference
abstracts.

2.3.3 Data extraction and management
After scanning the titles and abstracts of the identified studies, duplicate articles or those not
related to the topic of interest were removed. Studies deemed to be relevant to the review were
retrieved and assessed for eligibility. Data extraction was performed by two authors and
included study design, subject characteristics and duration of symptoms, type of intervention,
outcome measures, follow-up intervals, as well as methods of data analysis and research
findings (Table 1).

2.3.4 Assessment of risk of bias in included studies
A calibration review was performed by the most experienced researcher (J.M.) and two coauthors (G.N. and P.B.) performed risk of bias assessments. Pairs of authors (G.N. and P.B.)
independently applied the quality assessment tool for quantitative studies (Cochrane Risk of
Bias tool) [27] on the eligible studies, and any disagreement was resolved by J.M. The authors
followed the usual procedures to use the six domains documented in this tool to assess the risk
of bias in the eligible studies [27].

2.3.5 Measures of treatment effect
A meta-analysis was considered at the initial plan of this systematic review as described in our
published protocol on PROSPERO (https://www.crd.york.ac.uk/PROSPERO) (Registration #:
CRD42018084090). However, due to the wide range of physiotherapeutic interventions (lack
of similar interventions) assessed across the included studies, a meta-analysis was not

33

performed. To assess the effectiveness of the interventions in the included trials, (i.e. the
magnitude of the effects), we calculated the between group effect sizes by reporting the
Standardized Response Mean (SRM) = δᵪ / SDδᵪ

. The δᵪ is the mean between-group

[28]

differences, and the SDδᵪ is the pooled standard deviation reflecting the variability of change
between the two groups [28]. To allow and facilitate clinical decision making, benchmark values
of trivial (< 0.20), small (≥ 0.20 to < 0.50), moderate (≥ 0.50 to < 0.80) or large (≥ 0.80),
proposed by Cohen, were utilized

[28]

. In trials where SRM calculation was not possible (due

to lack of SD reporting), we calculated and reported the between group mean differences.

2.3.6 Assessing the quality of individual RCTs
We used the Grading of Recommendations, Assessment, Development and Evaluations
(GRADE) approach for systematic reviews, (GRADE guidelines: 4. Rating the quality of
evidence – study limitations – risk of bias; GRADE guidelines: 5. Rating the quality of
evidence – publication bias; GRADE guidelines 6. Rating the quality of evidence – imprecision
(how precise is the effect size?); GRADE guidelines: 8. Rating the quality of evidence –
indirectness (difference between the population of interest and those who have participated in
relevant studies)

[29–33]

, to assess the quality of individual RCTs related to three outcomes;

shoulder pain, shoulder ROM and measures of shoulder function and disability. The quality
rating of individual RCTs for each outcome across trials was performed to provide the extent
of our confidence that the estimates of the effect were correct. The GRADE approach resulted
in an assessment of the quality of individual RCTs for each outcome across trials as high,
moderate, low, or very low [29–33].

2.4 Results
2.4.1 Characteristics of included studies
Our search strategy generated 165 articles on MEDLINE and 650 articles in total (Figure 1).
After applying the inclusion and exclusion criteria, 10 studies were eligible to be included. Of
these 10 studies, two studies were excluded because the full study was not published
(conference abstracts). Eight studies were evaluated and data from these studies were extracted
and summarized in Table 2. Among these eight studies, two studies were translated from
Chinese [34] and Persian [35] languages into English language by two native language speakers.
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All these studies were RCTs that assessed the effectiveness of physiotherapeutic interventions
(joint mobilization, laser therapy, continuous passive motion, electrotherapy, reflexology,
therapeutic exercises) [34,36–38], corticosteroid injection [39–41], and MUA [35] used to manage AC
in patients with diabetes. The eight eligible studies ranged in size from 30–147 patients and
included a total of 340 patients with diabetes. The main diagnosis was AC, and the mean age
in studies ranged from 53 to 61 years. The duration of follow up ranged from two weeks to 12
months.

2.4.2 Risk of Bias Assessment
We completed a risk of bias assessment for each study and illustrated this in Figure 2. The
main potential source of bias was performance bias in all eight RCTs, as a result of inadequate
blinding of study participants and personnel [34–41]. Furthermore, seven RCTs were rated at high
risk of selection bias due to unclear or lack of adequate random sequence generation [34–38] and
allocation concealment
detection bias
[34,35,39–41]

. Six trials demonstrated inadequate blinding of assessors –

[34,35,37–41]

[34,35,37–39,41]

. In addition, five RCTs were rated at high risk of attrition bias

and four RCTs at high risk of reporting bias

[34,35,37,41]

, due to incomplete outcome

data and selective reporting respectively.

2.4.3 Interventions
A wide range of non-surgical interventions were evaluated in the included trials:
1.

Mulligan mobilization, pendular exercise and home exercise program vs. Maitland
mobilization, pendular exercise and home exercise program [38].

2.

Low-level laser therapy plus stretching exercises vs. Reflexology (thumb walk) plus
stretching exercises [37].

3.

Intra-articular corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDS) plus
home exercise program vs. NSAIDS plus home exercise program [41].

4.

Triamcinolone acetonide (40 mg) injection and home exercise program vs
triamcinolone acetonide (20 mg) injection and home exercise program [40].

5.

Continuous passive motion plus electrotherapy vs. active exercises plus electrotherapy
[36]

.

6.

500 mg Naproxen (NSAID) and home exercise program vs. 40 mg triamcinolone and
home exercise program [39].
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7.

Oral medication and exercises (control) vs. Super laser plus control vs. Super laser and
thermotherapy plus control [34].

8.

Manipulation under anesthesia (MUA), corticosteroid plus exercises for patients with
diabetes vs. MUA plus exercises for patients without diabetes [35].

2.4.4 Outcome measures
Outcomes reported in studies were classified as: patient-reported shoulder pain (VAS) [34,36,39–
41]

, shoulder range of motion (goniometer)

[34,36–41]

, and measures of shoulder function and

disability (SPADI [36,38], CSS [35,36], ASES [40,41] and SST[40]).

2.4.5 Effects of interventions
Effects of Mulligan mobilization, pendular exercise and home exercise program vs. Maitland
mobilization, pendular exercise and home exercise program:
One trial (n = 30) assessed the effectiveness of Mulligan vs. Maitland techniques (both
including pendular exercise and home exercise program), on shoulder range of motions and
shoulder function and disability (SPADI), at six weeks follow up

[38]

. Mulligan techniques

including pendular exercise and home exercise program demonstrated large effects in terms of
improving shoulder range of motion, when compared to Maitland techniques with pendular
exercise and home exercise program, at six weeks follow up

[38]

. SRM of 1.30, 1.08 and 1.0

were calculated and reported for flexion, abduction and external rotation range of motions
respectively (high risk of bias; GRADE: very low quality). Similarly, Mulligan techniques
(plus pendular exercise and home exercise program), displayed large effects (SRM = 2.0) in
terms of improving shoulder function and disability, when compared to Maitland techniques
(plus pendular exercise and home exercise program), at six weeks follow up (high risk of bias;
GRADE: very low quality) (Table 2) [38].

Effects of low-level laser therapy plus stretching exercises vs. reflexology (thumb walk) plus
stretching exercises:
One trial (n = 44) assessed the effectiveness of low-level laser therapy vs. reflexology (both
including stretching exercises), on shoulder range of motion at eight weeks follow up [37]. We
calculated and reported the between-group mean differences because SRM calculation was not
possible due to lack of SD reporting. Low-level laser therapy plus stretching exercises

36

demonstrated between-group improvements of 14.5° (shoulder flexion), 14.0° (shoulder
abduction) and 13.0° (shoulder external rotation), when compared to reflexology (plus
stretching exercises), at eight weeks follow up ( high risk of bias; GRADE: very low quality)
[37]

.

Effects of intra-articular corticosteroids, NSAIDs plus home exercise program vs. NSAIDs plus
home exercise program:
One trial (n = 45) assessed the effectiveness of intra-articular corticosteroid plus NSAIDs and
a home exercise program vs. NSAIDs plus a home exercise program on shoulder pain and
range of motion at 24 weeks follow up

[41]

. Intra-articular corticosteroid plus NSAIDs and a

home exercise program demonstrated between-group improvements of 0.4 points on VAS (0
– 10), when compared to NSAIDs plus a home exercise program, at 24 weeks follow up
(GRADE: very low quality)

[41]

. Intra-articular corticosteroid plus NSAIDs and a home

exercise program displayed significant between-group improvements of 8.0° (shoulder forward
elevation) and 2.0° (shoulder external rotation), when compared to NSAIDs and a home
exercise program group, at 24 weeks follow up (high risk of bias; GRADE: very low quality)
[41]

. Intra-articular corticosteroid plus NSAIDs and a home exercise program displayed

between-group improvements of 4.0 points on ASES, when compared to NSAIDS and a home
exercise program group, at 24 weeks follow up (high risk of bias; GRADE: very low quality)
[41]

.

Effects of continuous passive motion plus electrotherapy vs. active exercises plus
electrotherapy:
One trial (n = 41) assessed the effectiveness of continuous passive motion vs. active exercises
(both including electrotherapy), on shoulder pain, range of motion and shoulder function and
disability (SPADI and CSS), at four weeks follow up

[36]

. Continuous passive motion plus

electrotherapy demonstrated large effects (SRM = 1.0) in terms of reducing shoulder pain
levels (pain in motion), when compared to active exercises plus electrotherapy, at four weeks
follow up (high risk of bias; GRADE: very low quality)

[36]

. Continuous passive motion plus

electrotherapy demonstrated moderate to large effects in terms of improving shoulder range of
motion, when compared to active exercises plus electrotherapy, at four weeks follow up (high
risk of bias; GRADE: very low quality)

[36]

. SRM of 2.0, 1.2 and 0.8 were calculated and

reported for flexion, abduction and external rotation range of motion respectively. Continuous
passive motion plus electrotherapy demonstrated large effects in terms of improving shoulder
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function and disability, when compared to active exercises plus electrotherapy, at four weeks
follow up (high risk of bias; GRADE: very low quality) [36]. SRM of 1.3 (SPADI – pain), 0.9
(SPADI – disability) and 1.1 (CSS) were calculated and reported (Table 2) [36].

Effects of 500 mg Naproxen (NSAIDs) and a home exercise program vs. 40 mg triamcinolone
and a home exercise program:
One trial (n = 57) assessed the effectiveness of 500 mg Naproxen vs. 40 mg triamcinolone
(both including a home exercise program), on shoulder range of motion and pain levels (at
rest), at 24 weeks follow up

[39]

. Triamcinolone plus a home exercise program demonstrated

trivial to moderate effects in terms of improving shoulder range of motion, when compared to
Naproxen plus a home exercise program, at 24 weeks follow up (high risk of bias; GRADE:
very low quality)

[39]

. SRM of 0.2 and 0.5 were calculated and reported for flexion and

abduction range of motions respectively. Triamcinolone plus a home exercise program
displayed trivial effects (SRM = 0.1) in terms of reducing shoulder pain levels, when compared
to Naproxen plus a home exercise program at 24 weeks follow up (high risk of bias; GRADE:
very low quality) (Table 2) [39].

Effects of oral medication and exercises (control) vs. laser therapy plus control vs. laser
therapy, thermotherapy plus control:
One trial (n = 84) assessed the effectiveness of control vs. laser therapy plus control vs. laser
therapy and thermotherapy plus control, on shoulder pain levels, at 20 days follow up [34]. Laser
therapy and thermotherapy plus control, demonstrated between-group improvements of 5.0 and
0.9 points on VAS (0 – 10), when compared to the control group, and laser therapy plus control
[34]

group at 20 days follow up, respectively (high risk of bias; GRADE: very low quality)

.

Laser therapy plus control displayed between-group improvements of 4.1 points on VAS (0 –
10), when compared to the control group alone at 20 days follow up (high risk of bias; GRADE:
very low quality) [34].

Effects of triamcinolone acetonide (40 mg) injection and home exercise program vs.
triamcinolone acetonide (20 mg) injection & home exercise program:
One trial (n = 147) assessed the effectiveness of triamcinolone acetonide (40 mg) injection vs
triamcinolone acetonide (20 mg) injection (both including a home exercise program), on
shoulder range of motion, pain, function and disability levels at 12 months follow up

[40]

. In

this trial, a subgroup analysis of patients with diabetes was performed but only the analysis of
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blood parameters was provided. Therefore, we were unable to calculate and report effect sizes
or between-group improvements (mean differences) of ASES and shoulder ROM (high risk of
bias; GRADE: very low quality) [40].

Effects of MUA, corticosteroid and exercises vs. MUA and exercises:
One trial (n = 26, a mix of patients with and without diabetes) assessed the effectiveness of
MUA plus corticosteroid vs. MUA (both including shoulder exercises), on shoulder function
at six months follow up [35]. The primary group analysis revealed a non-significant difference
between patients who received MUA plus corticosteroids and who received only MUA
regardless of diabetes status. The authors provided another subgroup analysis of patients with
(n=12) and without diabetes (n=14). MUA for patients without diabetes demonstrated betweengroup improvements of 5.6 points on CSS, when compared to MUA for patients with diabetes
(high risk of bias; GRADE: very low quality) [35].

2.5 Discussion
This review identified very low quality RCTs (all at high risk of bias) that demonstrated
benefits of a variety of non-surgical treatments in managing shoulder pain, ROM and function
in patients with diabetes who have AC. Therefore, we have very little confidence in the effect
estimates of these individual RCTs, or which treatments might be more beneficial.
In this systematic review, joint mobilization plus exercises [38], continuous passive motion with
electrotherapy [36] and low-level laser therapy [37] demonstrated larger effects (better outcomes)
on pain, ROM and function than other physiotherapeutic interventions. In addition,
corticosteroids plus exercise were found to reduce pain, improve shoulder function and ROM
when compared to NSAIDs plus exercise [39,41]. Lastly, shoulder function was improved with
MUA in patients with diabetes, however, this improvement was less pronounced when
compared to patients without diabetes [35].
Previous systematic reviews that investigated the effectiveness of different interventions for
managing AC have reported conflicting conclusions. A meta-analysis of three RCTs with
severe heterogeneity revealed a short-term effect of corticosteroids (effect estimate= 0.5-0.8)
over joint mobilization plus exercises (effect estimate = 0.1-0.7) on pain, ROM, and function
[13]

. Similarly, corticosteroid injection with poor evidence was found to provide small short-

term benefits on pain when compared to joint mobilization [18]. Another systematic review, that
did not include a formal meta-analysis or effect size calculations, found that joint mobilization
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plus exercises and laser therapy reduced pain and improved function

[16]

. Two systematic

reviews with high risk RCTs recommended the use of laser therapy and corticosteroids to
reduce pain and the use of joint mobilization to improve shoulder ROM and function

[14,17]

which concur with the findings of the current review. Lastly, MUA did not show additional
benefits over the use of other non-surgical or surgical interventions [15,17].
The assessment of methodological quality of individual studies varied in these systematic
reviews and there was no definitive consensus of the best treatment option for treating AC. In
addition, some systematic review authors have recommended a separate analysis of patients
with and without diabetes to consider the effect of different etiologies on the treatment effects
[15,17]

.

In comparison to the current systematic review, the large effects of some physiotherapeutic
interventions (mobilization plus exercises and continuous passive motion) over the
corticosteroids may be due to the long-lasting symptoms in patients with diabetes that
permitted a longer follow-up period

[12]

. However, the overall evidence in this systematic

review is of low quality and limits our ability to make recommendations on the best
intervention for managing AC in patients with diabetes.
Clinicians should be aware that the pathophysiology and natural history may not be consistent
with current evidence, and that much is yet unknown. Physicians should ensure that therapists
are aware of the patient's diabetic status since this may affect recovery or response to treatment.
Physiotherapists should be aware of emerging evidence on AC since the potential for changes
in best practice is high given the low quality of current evidence.

2.5.1 Study limitations
This systematic review does have a number of limitations. There is very limited literature on
the effectiveness of physiotherapeutic interventions, corticosteroids injection, and other nonsurgical interventions for the treatment of AC in patients with diabetes. While there were few
RCTs that addressed the effect of physiotherapeutic interventions (joint mobilization, laser
therapy, continuous passive motion, electrotherapy, reflexology, therapeutic exercises), no
identical physiotherapeutic interventions or exercise programs were utilized in any of these
RCTs. Similar to the physiotherapeutic intervention’s trials, RCTs that assessed corticosteroid
injections did not follow an identical protocol that would permit meaningful comparisons. We
found only one RCT that addressed the effect of MUA for treating AC in patients with diabetes.
This was the result of only including studies that assessed outcomes in patients with diabetes.
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Although we included only RCTs, the interpretation of the results is hampered by many factors
which are related to the internal validity of these studies. All the RCTs were rated at high risk
of bias due to the flaws in the design, conduct, analyses and reporting of the results. In regard
to precision, some RCTs included relatively small number of patients with short follow-up
periods. Finally, the limited number of RCTs and variability in the interventions used precluded
meta-analyses. Future large-scale well designed RCTs involving patients with diabetes who
have AC are required to provide an accurate estimate of treatment effects.

2.6 Conclusion
Very low-quality evidence indicated that a combination of physiotherapeutic interventions
(exercises, modalities, mobilization), NSAIDs and/or corticosteroid injections, can have trivial
to large effects in terms of improving shoulder function/disability, range of motion and pain
levels, in managing AC in patients with diabetes. Future high quality RCTs are needed to
determine the best intervention for managing AC in patients with diabetes and to improve the
confidence and precision of estimated effects.
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Box 1: MEDLINE search strategy

#1,"Search diabetes"
#2,"Search (adhesive capsulitis OR frozen shoulder)"
#3,"Search (physiotherapy OR exercise OR manual therapy OR joint
mobilization)"
#4,"Search ((diabetes) AND ((adhesive capsulitis OR frozen shoulder))) AND
((physiotherapy OR exercise OR manual therapy OR joint mobilization))"
#5,"Search ((modalities OR electrotherapy OR rehabilitation OR
corticosteroids))"
#6,"Search ((diabetes) AND ((adhesive capsulitis OR frozen shoulder))) AND
(((modalities OR electrotherapy OR rehabilitation OR corticosteroids)))"
#7,"Search ((manipulation under anesthesia OR arthroscopy OR
hydrodilatation OR suprascapular nerve block))"
#8,"Search ((diabetes) AND ((adhesive capsulitis OR frozen shoulder))) AND
((manipulation under anesthesia OR arthroscopy OR hydro dilatation OR
suprascapular nerve block))"
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Table 1: A summary of the included RCTs
Author, year

Patients
characteristics

Kim
2017

al.

n = 147
- Group 1: 40 mg
triamcinolone
injection (n= 76,
23M+53F, age =
57.4 (45-76), n of
diabetes = 13)
- Group 2: 20 mg
triamcinolone
injection (n= 71,
18M+53F, age =
56.34 (47-78), n of
diabetes = 14)

Ekim et al.
2016

n = 41
- Group 1: CPM
(n= 20, 7M+13F,
age = 60.58.1)
- Group 2: CPT
(n= 21, 8M+13F,
age = 60.46.7)

et

DOS
(months) &
DOD (years)
DOS: at least 2
months
DOD: N/A

DOS:
- Group 1: 10.5
- Group 2: 8.0
DOD:
- Group 1:
10.64.8
- Group 2:
7.955.4

Intervention

Outcome measures

Follow-up
periods

Group
1:
40
mg
triamcinolone
acetonide
injection under sonography
guide
Group
2:
20
mg
triamcinolone
acetonide
injection under sonography
guide
- Both groups started HEP after
injection (pendulum & selfstretching
passive
ROM
exercise in every plane for 4
weeks,
pulley
exercise,
isometric and strengthening
exercises with dumbbells
started 8 weeks after injection).
Group 1: CPM 1 h/day for 4
weeks (5 days/week)
Group
2:
CPT
(active
stretching, ROM & pendulum
exercises 1 h/day for 4 weeks
(5 days /week)
Both groups received 20 min
hot-pack, 5 min US, 20 min
TENS, and HEP for 8 weeks
(pendulum and passive ROM
exercises)

- Pain at rest: VAS scale
(0-10)
- ROM: flexion, ER
using
goniometer
(degrees) & IR; ability
to reach scapula with tip
of the thumb (0-4
points)
- ASES score
- SST
Blood
glucose,
fructosamine,
and
HbA1c

Baseline, 3ed, 6th,
12th weeks, 6 and
12 months after
injection,
and
again at the final
follow-up

- Pain: VAS scale (010) at rest, night, &
during motion
- Active & passive
ROM:
flexion,
abduction, ER using
goniometer (degrees)
and IR; ability to reach
scapula with tip of
thumb (degrees)
- CSS & SPADI:
shoulder pain and
function

Baseline, 4th, 12th
weeks

Research findings
from baseline to last session (MeanSD, pvalue)
The subgroup analysis of patients with diabetes
was not summarized for the clinical scores.
Authors provided data for blood glucose,
fructosamine, and HbA1c levels. Authors
reported a significant higher blood glucose
level of patients with diabetes at 6 weeks after
injection in group 1 compared with patients
with diabetes in group 2 (p = 0.01)

Group 1:
- Pain at rest 5.01.6 - 2.61.1 (0.001)
- Pain on motion 7.41.5 - 4.01.1 (0.001)
- Pain at night 8.151.09 - 4.350.88 (0.001)
- Active abduction 86.514.0 - 123.815.4
(0.001)
- Passive abduction 95.516.2 - 130.516
(0.001)
- Active flexion 103.915.8 - 14311.3 (0.001)
- Passive flexion 11215.9 - 150.511 (0.001)
- Active ER 31.519.6 - 58.015.0 (0.001)
- Passive ER 38.321.7 - 65.315.1 (0.001)
- Active IR 41.321.0 - 70.313.2 (0.001)
- Passive IR 46.020.9 - 77.010.9 (0.001)
- SPADI pain 79.18.2 - 50.09.1 (0.001)
- SPADI disability 67.59.2 - 42.88.3 (0.001)
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Youssef et al.
2015

n = 30
Group
1:
Mulligan (n= 15,
age = 54.85.85)
Group
2:
Maitland (n= 15,
age = 53.45.23)

DOS: at least 3
months
DOD: at least
5 years

- Group 1: Mulligan joint
mobilization techniques, 3
times / week for 6 weeks.
Passive
accessory
glide
combined with active arm
motion in three sets of 10
repetitions in each direction
- Group 2: Maitland joint
mobilization techniques, 3
times / week for 6 weeks.
Oscillatory
end-range
mobilization grade III or IV
- Both groups received
pendulum exercises in all
directions for 5 min and HEP
(pendulum
exercise
and
ADLs)

- SPADI
- Active ROM: flexion,
abduction, IR, and ER
using a digital level
inclinometer

Baseline
weeks

and

6

- CSS 32.18.5 - 50.85.6 (0.001)
Group 2:
- Pain at rest 5.91.4 - 3.71.5 (0.001)
- Pain on motion 7.81.3 - 5.21.5 (0.001)
- Pain at night 8.620.86 - 5.861.74 (0.001)
- Active abduction 90.711.1 - 111.915.4
(0.001)
- Passive abduction 97.912.5 - 119.517.4
(0.001)
- Active flexion 113.810.6 - 131.412.7
(0.001)
- Passive flexion 118.310.2 - 13912.4
(0.001)
- Active ER 42.1414.7 - 55.517.6 (0.001)
- Passive ER 48.815.5 - 61.717.6 (0.001)
- Active IR 46.212.0 - 62.617.9 (0.001)
- Passive IR 52.111.3 - 68.117.1 (0.001)
- SPADI pain 81.06.6 - 63.29.7 (0.001)
- SPADI disability 72.97.4 - 56.110.8
(0.001)
- CSS 32.87.5 - 43.48.3 (0.001)
Group 1:
- SPADI: 85.154.24 - 16.365.68 (p < 0.01)
- Flexion: 52.7410.51 - 144.2822.23 (p <
0.01)
- Abduction: 39.4615.55 - 133.8022.27 (p <
0.01)
- ER: 24.5711.16 - 83.866.38 (p < 0.01)
- IR: 45.66.01 - 69.466.61 (p < 0.01)
Group 2:
- SPADI: 82.37.21 - 32.7622.02 (p < 0.01)
- Flexion: 52.7812.73 - 119.3630.27 (p <
0.01)
- Abduction: 40.5719.69 - 111.9626.91 (p <
0.01)
- ER: 25.0114.14 - 73.314.72 (p < 0.01)
- IR: 45.735.44 - 67.567.21 (p < 0.01)
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- Authors also reported more improvement in
Mulligan group in SPADI and flexion,
abduction and ER ROM as compared to
Maitland group
Soliman et al.
2014

n = 44
- Group 1: Lowlevel laser therapy
(LLLT) (n= 20,
6M+14F, age =
59.553.03)
Group
2:
Reflexology (n=
20, 16M+4F, age
= 57.77.98)

DOS:
2-7
months
DOD > 4 years

- Group 1: LLLT for 15 min, 3
times / week for 8 weeks using
laser applicator
- Group 2: reflexology in the
form of thumb walk for 15 min,
3 times / week for 8 weeks in
upward,
downward
and
diagonal directions over the
shoulder area on the bottom of
the foot under the little toe
- Both groups received
exercise program for 15 min
(ER-passive stretch, forward
flexion-supine
position,
crossover arm stretch, pendular
exercise, hand behind back
exercise). Each exercise was
repeated 10 times

Shoulder
ROM:
forward
flexion,
abduction, IR, and ER
using
goniometer
(degrees)

Baseline, 4th, 8th
week

Dehghan
al. 2013

n = 57
Group
1:
Naproxen
(NSAID) (n= 28,
11M+17F, age =
52.86.7)
- Group 2: CS
injection (n= 29,
8M+21F, age =
55.37.7)

DOS <
months
DOD:
- Group
9.37.0
- Group
9.55.8

- Group 1: 500 mg Naproxen
(NSAID) twice daily
- Group 2: single injection of
40 mg triamcinolone under
sonography guide
Oral
NSAID
was
administered for all patients
who started HEP after 1 week
(shoulder flexion, abduction,
IR, 3 sessions/day, 15
reps/session).

- Pain at rest: VAS scale
(0-10)
ROM:
flexion,
abduction, ER using
goniometer (degrees) &
IR; ability to reach
scapula with hand (plus
0-4)

Baseline, 2nd, 6th,
12th, and 24th
weeks

et

6

1:
2:

No ROM values were summarized in a table
except for the baseline data.
Authors reported the following:
- Significant increase in abduction (p < 0.001)
in both groups at 4 and 8 weeks as compared to
baseline.
- Significant increase in ER (p < 0.001) at the 4
and 8 weeks in LLLT group compared to
baseline
- Reflexology was less effective at 4 and 8
weeks compared to LLLT group
- Significant increase in IR (p < 0.001) at 4 and
8 weeks in LLLT group
- Significant increase in IR (p <0.05) at 8 weeks
in reflexology group
- Significant increase in flexion (p <0.001) at 4
and 8 weeks in LLLT group
- Significant increase in IR (p <0.05) at 4 and 8
weeks in reflexology group but it was less than
LLLT group
Group1:
- Pain: 5.642.43 - 1.991.98 (0.001)
- Flexion: 107.615.7 - 167.622.0 (0.001)
- Abduction: 99.222.6 - 170.022.9 (0.001)
- ER: 28.29.5 - 45.79.8 (0.001)
- IR: 2.60.87 - 0.320.54 (0.001)
Group2:
- Pain at rest: 6.182.17 - 2.242.06 (0.001)
- Flexion: 103.722.3 - 167.424.2 (0.001)
- Abduction: 90.621.3 - 172.921.6 (0.001)
- ER: 30.811.7 - 47.411.4 (0.001)
- IR: 2.51.01 - 0.240.43 (0.001)
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Roh et
2012

al.

Liang et al.
2012

Guity et al.
2007

n = 45
- Group 1: CS
injection (n= 23,
16M+7F, age =
54.410.9)
Group
2:
NSAIDs (n= 22,
14M+8F, age =
55.311.2)

DOS:
- Group
6.24.3
- Group
6.54.0

n = 84
- Group 1: control
(n
=
28,
12M+16F, age =
54.363.87)
- Group 2: Super
laser (n = 28,
10M+18F, age =
53.643.29)
- Group 3: Super
laser
+
thermotherapy (n
= 28, 13M+15F,
age = 53.684.02)

DOS:
- Group
6.642.12
- Group
6.642.18
- Group
6.572.02

n = 26, 12 patients
with
diabetes
5M+21F

DOS: N/A

1:
2:

DOD: N/A

DOD: N/A

DOD: N/A

1:
2:
3:

- Group 1: intra-articular CS
composed
of
40
mg
triamcinolone acetonide under
sonography guide. Patients
were also offered oral
NSAIDs.
- Group 2: NSAIDs
- Both groups received HEP
initiated one day after injection
(4-quadrant stretching program
in flexion, ER, IR, and crossbody
adduction
for
3
times/day).
- Group 1: oral medication and
shoulder exercises 30 to 40
times per day for 20 days.
- Group 2: super laser using
probe (intermittent followed
by continuous irradiation for 7
min on each trigger point with
output power of 80 to 100%,
one time per day for 20 days) +
group 1 treatment.
Group 3: including the
treatment of group 1 and 2 in
addition to thermotherapy
(using
fumigation
tank,
temperature between 38 to
45℃, 30 min per day for 20
days). Traditional Chinese
medicine was added to the tank
(medicine names and amounts
are listed in the original
article).

- Pain at rest: VAS scale
(0-10)
- ROM: passive flexion,
ER at 0 abduction using
goniometer (degrees) &
IR; ability to reach
scapula with tip of the
thumb (0-10 points)
- ASES score

Baseline,
12th, and
week

4th,
24th

No values were presented for pain, ROM, and
ASES.
Authors reported the following: - Significant
lower VAS scores in group 1 at 4-week followup (p = 0.02)
- Flexion (p = 0.03) and IR (p = 0.045) ROM
were higher in group 1 at 12-week follow-up
than group 2
- Significant difference in ASES between
groups at 12-week follow-up

- The degree of
shoulder pain (VAS)
and shoulder movement
(integral score) as
follow:
* Cure:
VAS = 0
Integral score = 0
* Effective:
0 <VAS≤ 2
Integral score: ≤ 4
points
* General:
2 <VAS≤ 5
Integral score: from 5 to
7 points
* Invalid:
VAS> 6
Integral score is 8 to 12
points

Baseline, and 20
days
after
treatment

- Group 1: (n = 28,%)
Cure 0 (0)
Effective 1 (3.57)
General 5 (17.86)
Invalid 22 (78.57)
- Group 2: (n = 28,%)
Cure 7 (25)
Effective 11 (39.28)
General 10 (35.72)
Invalid 0 (0)
- Group 3: (n = 28,%)
Cure 12 (42.85)
Effective 10 (35.71)
General 6 (21.44)
Invalid 0 (0)
The authors reported that the greatest
improvement was noted in group 3 as
compared to the other two groups. Group 2 had
also better outcomes compared to group 1
(control).

Group 1: MUA + CS.
Intravenous CS was provided
prior to manipulation which

Pain and ROM: CSS
questionnaire (0-100)

Baseline, two and
six weeks, then

Authors reported statistically significant
improvement in both groups overtime with a
non-statistically significant difference between
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Age = 55.75.1
- Group 1: MUA +
CS injection (n =
13)
- Group 2: MUA
(n = 13)
Another subgroup
analysis
for
patients
with
diabetes (n=12)
and
patients
without diabetes
(n= 14) were
provided when the
effect
of
CS
between
the
primary
groups
was
nonsignificant

was done from supine position
while the affected shoulder
was flexed, and then moved
into 90 degrees of abduction
and then rotated outward.
All patients received shoulder
exercises.
Group 2: MUA and shoulder
exercises.

three and
months

six

patients who received MUA +CS and only
MUA:
Group 1:
Before MUA: 29.47.4
After MUA: 86.98.5
Group 2:
Before MUA: 284.2
After MUA: 82.75.1
From the sub-analysis of patients with diabetes:
Patients with diabetes:
Before MUA: 25.93.2
After MUA: 794.9
Patients without diabetes:
Before MUA: 31.16.8
After MUA: 89.84.6
Authors reported a statistically significant
difference between patients with and without
diabetes (p = 0.01)

RCT: randomized clinical trial, NSAID: non-steroidal anti-inflammatory drug, CS: corticosteroids, M: male, F: female, DOS: duration of symptoms, DOD: duration of diabetes, HEP: home exercise program, IR: internal
rotation, ER: external rotation, VAS: visual analogue score, ROM: range of motion, CPM: continuous passive motion, CPT: conventional physiotherapy treatment, CSS: constant shoulder score, SPADI: shoulder pain
and disability index, US: ultrasound, TENS: transcutaneous electrical nerve stimulation, ASES: American shoulder and elbow surgeons, SST: simple shoulder test, MUA: manipulation under anesthesia.
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Figure 1: Flow diagram showing study selection process
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Figure 2: Risk of bias summary- review authors’ judgements about each risk of bias item for
each included study
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Table 2: A summary of the original outcome measures and the Standardized Response Mean
Study

Ekim et al. 2016

Outcome measure mean and SD
- Group 1: pain in motion 7.41.5 - 4.01.1
- Group 2: pain in motion 7.81.3 - 5.21.5

1.0

- Group 1: active flexion 103.915.8 - 14311.3
- Group 2: active flexion 113.810.6 - 131.412.7

2.0

- Group 1: active abduction 86.514.0 - 123.815.4
- Group 2: active abduction 90.711.1 - 111.915.4

1.2

- Group 1: active ER 31.519.6 - 58.015.0
- Group 2: active ER 42.1414.7 - 55.517.6

0.8

- Group 1: SPADI pain 79.18.2 - 50.09.1
- Group 2: SPADI pain 81.06.6 - 63.29.7

1.3

- Group 1: SPADI disability 67.59.2 - 42.88.3
- Group 2: SPADI disability 72.97.4 - 56.110.8

Youssef et al. 2015

Dehghan et al. 2013

SRM

- Group 1: CSS 32.18.5 - 50.85.6
- Group 2: CSS 32.87.5 - 43.48.3
- Group 1: SPADI 85.154.24 - 16.365.68
- Group 2: SPADI 82.37.21 - 32.7622.02

0.9

1.1
2.0

- Group 1: flexion: 52.7410.51 - 144.2822.23
- Group 2: flexion: 52.7812.73 - 119.3630.27

1.30

- Group 1: abduction: 39.4615.55 - 133.8022.27
- Group 2: abduction: 40.5719.69 - 111.9626.91

1.08

- Group 1: ER: 24.5711.16 - 83.866.38
- Group 2: ER: 25.0114.14 - 73.314.72
- Group 1: pain: 5.642.43 - 1.991.98
- Group 2: pain 6.182.17 - 2.242.06

1.0
0.1

- Group 1: flexion: 107.615.7 - 167.622.0
- Group 2: flexion: 103.722.3 - 167.424.2

0.2

- Group 1: abduction: 99.222.6 - 170.022.9
- Group 2: abduction: 90.621.3 - 172.921.6

0.5

SRM: Standardized Response Mean, SD: standard deviation, ER: external rotation, SPADI: shoulder pain and disability index, CSS:
constant shoulder score.
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CHAPTER 3:
PHYSIOTHERAPY EXERCISE PROGRAM FOR MANAGING
ADHESIVE CAPSULITIS IN PATIENTS WITH AND
WITHOUT DIABETES: A PILOT RANDOMIZED TRIAL

The manuscript is submitted to the Archives of Orthopaedics

Alsubheen SA, MacDermid JC, Overend TJ, Faber KJ, Furtado R. Effect of physiotherapy
program on shoulder performance for managing adhesive capsulitis in patients with diabetes:
A pilot randomized trial. Submitted to the Archives of Orthopaedics Journal.
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Abstract
Study design: Prospective randomized pilot trial
Background: Adhesive capsulitis (AC) occurs five times more often in people with diabetes.
Exercises are usually recommended to manage AC. However, the recovery is slow and often
incomplete, especially for patients with diabetes. Aerobic exercises improve hyperglycemia
and insulin sensitivity. Currently, no research has formally assessed the benefits of
incorporating an aerobic walking training program into the treatment plan of AC in patients
with diabetes.
Purpose: This pilot trial compared the effect of a regular physiotherapy (PT) program (PT) to
a regular PT program combined with a progressive walking program (PT+) in patients with
and without diabetes who have AC.
Methods: Eight patients with (n = 3) and without (n = 5) diabetes (five men and three women,
with mean age of 57 years) were included. Patients were randomly allocated either to PT or
PT+ groups. The primary outcome of shoulder function was measured using the Functional
Impairment Test-Hand and Neck/Shoulder/Arm (FIT-HaNSA) test. Secondary outcomes
included shoulder pain and function; shoulder range of motion in flexion, abduction, and
external rotation; muscle strength of shoulder flexors and abductors; and physical activity level.
The primary outcome was evaluated at baseline and after six weeks. Secondary outcomes were
evaluated at baseline, and after three, six and 12 weeks from enrollment.
Setting: Single centre study at a tertiary-care hospital.
Results: A total of 13 patients were contacted with study details, only eight patients agreed to
participate, with a 62% recruitment rate. Adherence with research centre visits was 97%.
Patients in both groups showed improvement in all outcome measures. The FIT-HaNSA scores
had a mean improvement of 3817 in the PT group and 633 in the PT+ group from baseline
to six weeks follow-up. Future studies, with 80% power (α= 0.05, β= 0.20) to detect a 20%
between-group difference, would require a sample size of 89 participants per group.
Conclusion: This pilot trial established that conducting a large-scale study to assess the effect
of physiotherapy program for managing AC is feasible. The current findings suggest that
physiotherapy exercises may be effective in reducing pain and improving shoulder function
and ROM in patients with and without diabetes who have AC. Researchers should be aware of
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the recruitment challenges and should work on minimizing performance and detection bias by
blinding study personnel and outcome assessors.

Trial registration: ClinicalTrials.gov, ID number: NCT03462420. Registered 30 January
2018, https://register.clinicaltrials.gov/prs/app/action/LoginUser?ts=2&cx=-jg9qo3
Keywords: Adhesive capsulitis, Diabetes, Physiotherapy, Pilot trial
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3.1 Background
Adhesive capsulitis (AC), also known as ‘frozen shoulder’, is characterized by the
development of dense adhesions and capsular thickening leading to a progressive and painful
restriction of shoulder range of motion (ROM) and functional disability

[1]

. The onset is

gradual, usually occurs between the ages of 40 and 60 years [2] and is more common in females
and patients with diabetes [3].
Adhesive capsulitis has been described as a self-limiting condition that progresses through
pain, frozen and thawing phases. However, Wong et al. examined the quality of the evidence
that describes the theory of AC phases and reported a lack of evidence to support these
theoretical phases of AC [4].
Based on Codman’s criteria

[5]

, the condition can be classified as primary or secondary AC.

Primary or idiopathic AC has no clear underlying cause

[5]

. However, secondary AC might

develop following soft tissue injury, joint arthritis, or secondary to known systemic disease
such as diabetes [6]. The association between diabetes and AC was first reported by Bridgman
(1972) who found that 10.8% of patients with diabetes had AC as compared to 2.3% for patients
without diabetes

[7]

. Subsequent studies have supported this association and reported a

prevalence of AC in 10-76% type 1 and 7-30% type 2 diabetes as compared to 0-10% in the
general population

[1,8–11]

. Adhesive capsulitis was also reported to be associated with age in

both types of diabetes [8] and with the duration in type 1 diabetes [9,10,12].
The pathophysiology that predisposes patients with diabetes for the development of AC is not
well-understood. Proposed mechanisms that may lead to AC include increased glycosylation
of collagen fibers of the joint capsule and diabetic microangiopathy induced fibrosis [1,13,14].
The usual approach for managing AC includes steroid injections, joint mobilization techniques
and the implementation of shoulder exercises to restore function. Several systematic reviews
reported that active exercises and joint mobilization can reduce pain, restore shoulder ROM
and function in both short- and long-term follow up

[15–18]

, while moderate-quality evidence

showed a short-term beneficial effect of steroid injection in reducing pain during the early stage
of AC

[15–17,19]

. Only one recent systematic review has assessed the effectiveness of non-

surgical intervention for managing AC in patients with diabetes and reported that low quality
evidence suggests large effects of joint mobilization plus exercises on AC in patients with
diabetes with a weaker support for the use of steroid injection and manipulation under
anesthesia [20].
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Although some of the non-surgical interventions have been shown to be effective in managing
AC, recovery is slow and often incomplete, especially for people with diabetes

[21]

. Patients

with diabetes often develop long-lasting shoulder stiffness, higher shoulder pain, functional
disability and reduced ROM than patients without diabetes [9,10,22,23]. Furthermore, greater
shoulder pain and disability were associated with poor glycemic control and diabetic
complications [24].
Aerobic exercises can improve hyperglycemia and insulin sensitivity in skeletal muscle, and
induce a favorable effect on blood vessels that can reduce diabetes related complications such
as hypertension, hyperlipidemia, and obesity

[25]

. These effects may have a greater impact on

the AC pathophysiology. However, none of the previous research has formally assessed the
benefits of incorporating an aerobic training program into the treatment plan of AC in patients
with diabetes. At present, there is no optimal physical therapy protocol for managing AC in
patients with diabetes.
The purpose of this pilot randomized trial was to compare the effect of a regular physiotherapy
(PT) program to a regular PT combined with a progressive walking program (PT+) in patients
with and without diabetes who have AC. This pilot trial also evaluated the feasibility of
recruitment, randomization, retention, assessment procedures, and implementation of the novel
intervention. Data from this pilot trial was used to calculate an accurate sample size for a fullscale randomized clinical trial RCT. The secondary objective was to determine if diabetes
affects response to treatment.

3.2 Methods and materials
3.2.1 Study design and setting
A prospective single-blinded parallel pilot RCT was conducted at a tertiary hospital. Local
Research Ethics Board has approved the study (Project ID: 111647).

3.2.2 Inclusion and exclusion criteria
Inclusion criteria: 1) A confirmed diagnosis of AC. A diagnosis of AC was confirmed by the
consultant shoulder surgeon (KF), who was blinded to treatment allocation, based on the
following diagnostic criteria: shoulder pain for at least one month; inability to sleep on the
affected side; and restriction of active and passive ROM in one or more planes [26]; 2) Patients
aged 18 years or more; 3) Ability to participate in the study and follow treatment instructions.
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Exclusion criteria: Patients with previous shoulder surgery, significant shoulder injury within
six-months, history of shoulder dislocation or arthritis, and patients with suspected rotator cuff
disease were excluded from this study.

3.2.3 Outcome measures
3.2.3.1 Primary outcome measure
The primary outcome was the Functional Impairment Test - Hand and Neck/Shoulder/Arm
(FIT-HaNSA) test. The FIT-HaNSA test measures the functional performance of the upper
limb, while performing multi-level tasks. In the first task (waist-up), the patient lifts three onekg containers one at a time, with the affected arm, between a shelf at waist level and a shelf 25
cm higher at speed of 60 beats per minute for five minutes or until patient is unable to continue.
In the second task (eye-down), the patient returns the three containers back to the waist level
shelf. In the third task (overhead work), using both arms, the patient repeatedly screws and
unscrews bolts to simulate overhead work for five minutes or until the patient feels unable to
continue. Each task was timed with a stopwatch and the rhythmic speed was controlled using
an auditory metronome (Soundbrenner, Berlin). All tasks were performed from a standing
position. This test has been shown to be valid and reliable [27].

3.2.3.2 Secondary outcome measures
Secondary outcomes included shoulder range of motion (ROM) in flexion, abduction, and
external rotation using a standard goniometer; shoulder pain and function using Shoulder Pain
and Disability Index (SPADI) questionnaire; muscle strength of shoulder flexors and abductors
using a dynamometer; and physical activity level using an accelerometer (Fitbit) and the Rapid
Assessment of Physical Activity (RAPA) questionnaire. Secondary outcome measures were
collected by a single physiotherapist at baseline, and at three, six, and 12 weeks.

Shoulder ROM
Shoulder ROM was measured using a standard goniometer with known concurrent validity and
reliability [Intraclass Correlation Coefficients (ICCs) > 0.94] [28]. Active flexion and abduction
ROM were assessed by measuring the angle formed by the arm and thorax from sitting position.
The axis of the goniometer was located at the acromion process; the movable bar was parallel
to the humerus while keeping the stationary bar parallel to the trunk [29].
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Active external rotation was assessed in sitting position with the arm adducted and the elbow
at the side and flexed to 90 degrees. The axis of the goniometer was located at the olecranon
process of the elbow and both the stationary and movable bars were parallel to the forearm [29].

Shoulder pain and function
Shoulder pain and function were assessed using SPADI questionnaire

[30]

. This self-report

questionnaire consists of two subscales: pain (five items) and function (eight items). The pain
subscale is rated on scale from zero (no pain) to 10 (worst pain ever). The patient is asked to
circle the number that best describes their pain and/or disability. The subscale scores are
calculated by adding the item scores for that subscale and dividing this number by the
maximum score possible for the items that are deemed applicable by the subject. This number
is then multiplied by 100. The two subscales are then added and the total out of 130 is then
multiplied by 100. Higher scores indicate greater impairment or disability [30,31].
The SPADI has been shown to be a valid and reliable measure of shoulder pain and disability
[32]

. A SPADI score can detect change over time, accurately discriminates among patients who

have improved or worsened [31] and has been used in patients with AC [33,34].

Muscle strength
Isometric muscle strength was assessed for shoulder flexors and abductors using the JTech
Power Track handheld dynamometer (JTech; JTech Medical, Salt Lake City, UT, USA), with
known concurrent validity

[35]

and reliability (ICCs 0.89-0.98)

[36]

. Patients were seated on a

straight back chair to stabilize the trunk. Abductor strength was measured by placing the device
on the lateral aspect of mid-humerus and flexor strength was measured by placing the device
on the anterior aspect of the upper arm.

Assessment of physical activity level
Physical activity level was measured objectively using an accelerometer (Fitbit Zip) and
subjectively use a self-reported questionnaire (RAPA). Physical activity level was objectively
measured using the Fitbit Zip (Fitbit Inc, USA). This activity tracker contains a threedimensional accelerometer and is designed to track steps, distance and calories burned. Fitbit
Zip is small and discreet and can be worn in a pocket, on a belt or on a bra. Data from the Fitbit
Zip syncs automatically to a computer or smartphone using free online application software.
Participants were asked to wear the device during all waking hours and to sync their devices
on a daily basis for six consecutive weeks. Step count and distance data were obtained from
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the Fitbit Zip and summarised into an activity tracking sheet. This device has been validated
and found to be comparable to other accelerometers [37,38]. Physical activities were subjectively
assessed using RAPA which consists of nine self-reported questions that assess physical
activity levels with a response option of yes or no. The first seven questions assess weekly
aerobic activity ranging from sedentary to vigorous levels with a total score of 1-7 points,
where 1 = rarely do any physical activity, and 7 = 20 minutes of vigorous activities 3+
days/week. A respondent's physical activity score is categorized into one of five levels of
physical activity: sedentary, underactive, regular underactive (light activities), regular
underactive, and regular active. The other two questions assess strength and flexibility training
with a total score of three points; one point for strength training and two points for flexibility
training. A full description of RAPA is published

[39]

. The RAPA questionnaire has been

validated for use in clinical practice with older adults [39].

3.2.4 Procedures
Patients with and without diabetes, who have been diagnosed with AC were recruited from
orthopedic clinics at our tertiary hospital via surgeon referrals. Eligible patients were then
given a letter of information and were asked to sign a consent form. After signing the consent
form, patients attended an orientation session and were provided with information about the
study and the experimental design. Patient's weight, height, age, gender, type and treatment of
diabetes, affected shoulder side (right or left; dominant or non-dominant), and the duration of
AC symptoms were collected during this session. Patients were then asked to complete two
outcome questionnaires (SPADI and RAPA) and a Katz comorbidity scale [40].
Next, patients underwent blinded randomization into one of the two groups: regular PT
program or regular PT with a progressive walking program (PT+). The randomization was
stratified by intervention (walking program) and diabetes status using a computer-generated
random number table. Patients were allocated into groups using sequentially numbered,
opaque, and sealed envelopes issued by the blinded assistant research.
The initial intention of this study was to refer all patients to physical therapy facilities according
to their preferences. However, because some patients were recently completed their PT
treatment and some others were unable to start a formal PT treatment due to the long wait list
at physiotherapy clinics, those patients were provided with a home exercise program from the
research team. This program included a group of shoulder exercises that are proven to improve
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shoulder clinical outcomes in patients with AC. A detailed exercise program is described online
[41]

.

In the PT+ group, patients were instructed to walk at their own pace for 30-45 min, five days
per week for six consecutive weeks. They recorded their walking date/time on a diary form
provided by the research team. Patients in the PT+ group were not restricted from walking
more than 45 minutes a day, as long as they did not feel tired or uncomfortable. Patients in
both groups were provided with a Fitbit Zip accelerometer to accurately estimate their physical
activity level.
Diabetes Canada is recommending a minimum of 150 minutes per week of at least moderateintensity cardiorespiratory exercise to improve cardiovascular risk

[42]

. Improvements in

arterial stiffness and insulin resistance have been documented after only three weeks of aerobic
exercise training. To maintain a long-term effect, longer durations are recommended [43].
Walking is type of cardiorespiratory exercise training that is affordable and easy, costs nothing,
safe and gentle enough for patients with comorbidities and can be done anytime, just about
anywhere. However, patients with diabetes must be checked for the presence of diabetic foot
as this may prevent the ability of patients to walk due to the potential adverse effect of
weightbearing exercises on foot health [44].
The primary outcome measures were evaluated by a single research team member at baseline
and after six weeks. Secondary outcomes were evaluated at baseline, at three and six weeks,
and again at 12 weeks after enrollment (Figure 1).

3.2.5 Statistical Analysis
Statistical analysis was performed using SPSS, version 21 (SPSS Inc., Chicago, IL, USA). The
analysis of this pilot study is mainly descriptive. Estimates of means and standard deviations
for continuous outcomes measures, and an estimate of the proportion for categorical outcome
measures were calculated. The recruitment rate was calculated by dividing the total number of
patients who consented to participate by the total number of patients contacted with study
details. The attendance rate was calculated by dividing the actual number of visits by the total
number of all patients’ visits.

3.3 Results
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Thirteen consecutive patients with AC were referred by the orthopedic surgeon (KF) between
September 2018 and November 2019. Of the 13 patients contacted with study details, only
eight patients, including three patients with diabetes, agreed to participate in this study,
a 62% recruitment rate (8/13). Adherence with scheduled research centre visits was excellent
with a 97% attendance rate (31/32). Only one patient missed the final follow-up visit which
included completing SPADI and RAPA questionnaires and measures of active ROM and
muscle strength.
This study included five male and three female patients with mean age of 57 years. Table 1
presents the clinical characteristics of patients for both PT and PT+ groups. Six patients were
allocated in the PT group, including three patients with diabetes, and two patients were
allocated in the PT+ group. Patients in the PT group were overweight with a Body Mass Index
(BMI) of 26 and reported more comorbidities (Table 1).
Three patients (two in PT+) were enrolled in a formal physiotherapy program that included
ROM, stretching and strengthening exercises (two patients received one session/month; one
patient received 12 sessions: two sessions/week), and five patients were provided a home
exercise program by the research team (the five patients completed a formal PT program before
the beginning of this study which included PT modalities and exercises).

3.3.1 Change over time in outcome measures
All patients showed improvement over the six weeks follow-up time in the FIT - HaNSA
outcome measure (from 155±89 to 180±88). This improvement was more pronounced in the
PT group as illustrated in Table 2. Similarly, all patients had improvements in SPADI (pain,
function, total), active ROM (flexion, abduction, external rotation), and muscle strength
(flexors and abductors) over the 12-week follow-up period. The improvement of these outcome
measures was more pronounced in the PT group when compared to PT+ group (Table 2).
The physical activity level of both groups remained the same throughout the study (RAPA =
6) (Table 2). When comparing groups, the PT+ group was more active at the six and 12-week
follow-up times (RAPA = 7, 8, respectively) and showed higher step counts and longer
travelled distances over the six-week use of the Fitbit activity tracker (Table 3).

3.3.2 A comparison between patients with and without diabetes
Table 4 and 5 present a comparison between patients with and without diabetes for all outcome
measures. In general, patients with diabetes were younger (53±11 years) and had AC for a
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longer period of time (29±38 years). In addition, patients with diabetes had worse baseline
outcome measures and their improvement at six weeks was less pronounced when compared
to patients without diabetes. However, patients with diabetes showed higher improvement at
12-week follow-up period compared to patients without diabetes in response to a physiotherapy
exercise program (Table 4).
The level of physical activity for patients with diabetes was less at baseline (RAPA = 5) but
increased over time and became higher than patients without diabetes at week 12 (RAPA = 7).
However, patients without diabetes showed a higher step count and longer travelled distances
as compared to patients with diabetes over the six-week use of the Fitbit activity tracker as
presented in Table 5.

3.3.3 Sample size:
Sample size calculations were based on the mean FIT-HaNSA scores and the pooled Standard
Deviation (SD) at the six-week follow-up visit. We calculated the sample size for future studies
using the following equation [45]:

Where,
N = size per group;
1-β = the power to detect a difference if one truly exists; for 80% this is 0.84
α = the probability of making a Type I error = 0.05;
zx= the z-score/standard normal deviate for a two-sided x; for 5% this is 1.96
S2= Pooled standard deviation of both comparison groups = 88;
δ = a clinically acceptable margin = 36. This was determined by calculating a 20% clinically
important difference in the follow-up mean score.
N = 2 x (1.96 + 0.84 / 36)2 x (88)2 = 77 per group
Total = 2 x 77 = 154
Considering a drop-out rate of 15%, the total sample size required is 178 (89 per group).
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3.4 Discussion
This prospective randomized pilot trial determined that conducting a large-scale study to assess
the effect of physiotherapy program for managing AC is feasible. However, the effect of adding
a progressive walking program to PT exercises was not tested for patients with diabetes due
to the stratified randomization with this small sample; all patients with diabetes (n = 3) were
randomized to the regular PT program group.
Participant recruitment was satisfactory and there were no dropouts. For future studies, a
sample size of 178 (89 participants per group), to detect 20% difference between-groups is
required. Seven patients would need to be recruited each month over 26-month period to
successfully complete the trial in a single Centre. A multicenter approach may be more
pragmatic and efficient.
This study demonstrated that clinical outcomes including shoulder performance, shoulder pain
and function, active ROM, and muscle strength improved in patients with AC over a 12-week
follow-up period. The improvement was more pronounced in the PT group as compared to PT+
group; however, we consider these results unstable due to the very low sample size of PT+
group. However, patients in PT+ group were more physically active as indicated by RAPA and
Fitbit results. This can be due to the nature of our study in which the research team encouraged
patients in the PT+ group to perform regular walking activity. Provision of the Fitbit might in
itself have acted as a motivator for improving physical activity; since this is not standard
practice.
Although patients with diabetes had worse outcome measures at baseline, they improved
overtime and showed greater recovery at week 12 when compared to patients without diabetes.
At the 12-week follow-up visit, two patients without diabetes reported severe pain and inability
to move their arm after performing intensive housekeeping activities. This may explain the
inferior recovery in the patient without diabetes group. However, the level of physical activity
was lower in patients with diabetes at baseline as indicated by the Fitbit results although the
RAPA score was higher in patients with diabetes. The sample size was too small to detect
treatment differences and to make definitive conclusions. However, the preliminary findings
of this study, including the excellent adherence rate to research centre visits and the acceptable
recruitment rate show that the novel approach taken in this pilot trial is worthy of investigation
in future randomized trials.
It was difficult to recruit the required number of patients for this pilot trial. Although our
recruitment rate was acceptable (62%), not all patients agreed to take part in the trial and few
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(n=13) were referred to our centre. Patients had several reasons for refusing to participate in
the study including lengthy travel distances to the research centre and insufficient time to
commit to the study. The low recruitment rate in this trial may be due to the fact that patients
with early stages of AC are usually seen by primary care centres who prescribe patient
medications and refer them to physiotherapy facilities. The variable course of AC, the
variations in referral patterns as many practitioners are involved in the care of AC, the delays
from referral to specialist assessment, and the diagnostic uncertainty of AC limited us from
recruiting enough patients to this trial. In the future, large trials on patients with AC may be
best conducted at a primary care clinical setting.
The research team leader (SA) was not part of the clinical team and this also may have affected
recruitment of subjects for the study. In spite of the research leader regularly communicating
with other clinical team members such as physiotherapists and administrative people, the
recruitment was lower than expected. As this is a critical issue, improving communication
between researchers and clinical team members may be important.
In this trial, the rate of recruitment (62%) was acceptable and the rate of adherence (97%) was
excellent, with only one patient lost to a final follow-up session. Patients were required to
participate in many assessment sessions, an initial assessment session and in three more
assessment sessions (at three weeks, six weeks, and 12 weeks), and to attend physiotherapy
treatment sessions or perform the home exercise program. Both of these programs involved
time and effort from patients. This suggests that with the current methodology, a future study
is feasible and performing advanced statistical analysis with larger sample sizes seems
achievable. However, it is important to take into account that AC is a disabling condition and
patients are usually eager to try something to get their shoulder feeling better. If it was less
disabling, the adherence to the program would likely be lower.
Due to the random and concealed allocation of patients in this trial, selection bias was
minimized. In addition, patients in this trial were blinded to treatment groups, PT vs. PT+, and
were randomly referred to physiotherapy facilities that might minimized performance bias.
However, since some patients were given a home exercise program by the research leader,
there may be a source of performance bias. Further, the research leader performed all the
assessments and was aware of group allocations which is considered a source of detection bias.
The attrition rate was minimal during the baseline, three weeks, and six weeks assessment
sessions, however, at 12-week assessment session, one patient was lost to follow-up with an
attrition rate of 13%. Lastly, based on our initial registered protocol, all the mentioned primary
and secondary outcomes were collected and reported in this trial which minimized reporting
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bias. However, there was an intention to collect data at 24-week follow-up session, but because
patients were unwilling to attend this session, no data was collected.
The main aim of all AC physiotherapy programs is to relieve pain, improve function, increase
shoulder ROM and to improve the patient's quality of life. In the current literature, there is no
consensus on the most appropriate treatment for AC in patients with and without diabetes.[20,46]
Several studies have shown that physiotherapy interventions (mainly exercises) reduce pain,
restore shoulder function, and improve ROM in patients with and without diabetes who have
AC [15–18,47–51], which concur with the results of the current trial. However, the recovery might
be similar [52] or inferior [21] to patients without diabetes contradicting the results of this pilot
trial. Because of the very low sample size of patients with diabetes in this pilot trial, comparing
its results to other studies could be misleading.
The improvements in shoulder pain, function and motion of the shoulder joint following
physiotherapeutic interventions may be explained by the mechano-transduction mechanism by
which cells convert external mechanical stimuli or force (e.g. exercise and massage) into a set
of biochemical reactions that elicit adaptive responses in the tissue. For example, controlled
self-stretching exercises and vacuum massage are reported to be effective in promoting
collagen remodeling and maturation by breaking down adhesions and inducing collagen
realignment. These changes in turn reduce motion restriction, decrease pain and improve
function [53,54].
Fitbit Zip was reported as a valid activity tracker for recording step count and covered distance
[38]

. Our results in Table 3 showed some discrepancies between steps count and the actual

covered distance. Therefore, we would question the accuracy of this type of activity trackers
and recommend for the use of more accurate types of activity trackers in future trials.
Lastly, no previous research has investigated the effect of incorporating specific shoulder
exercises with aerobic training program to investigate shoulder recovery in patients with
diabetes who have AC. Aerobic exercises that improve hyperglycemia and insulin sensitivity
in skeletal musculature may have an impact on the pathophysiology of AC. Because none of
our patients with diabetes were randomized to the group that include regular walking program,
examining this effect was not possible. Future studies are required to examine the effect of
adding walking program to the shoulder specific exercises for managing AC and to assess if
walking is the ideal aerobic exercise for this population or other aerobic programs such as
swimming or biking.
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3.4.1 Strengths and limitations
The strengths of this study are: (1) All assessment sessions were performed by the research
leader which reduced assessment variations among patients; (2) This trial reduced selection
bias by having a computerized randomization process; (3) In this trial, the surgeon and the
research leader were trained and experienced in the field of shoulder rehabilitation which
contributed to the successful conduct of this trial. However, there are some limitations to this
pilot that need to be recognized: (1) Having a small sample size has reduced the power of this
trial; (2) The inability to blind the outcome assessor has introduced detection bias to this study;
(3) Since no patient with diabetes were randomized to the walking program, examining the
effect of incorporating aerobic program to specific shoulder exercise for managing AC was not
possible. However, future studies considering a walking program for patients with diabetes
must consider the presence of diabetic foot as this may prevent the ability of patients to do
walking due to the potential adverse effect of weightbearing exercises on foot health [44].

3.4.2 Clinical impacts and future research directions
-

This study suggests that physiotherapeutic exercises might be effective in reducing pain
and improving shoulder function in patient with and without diabetes who have AC.

-

Based on the findings of the current pilot trial, we have calculated the sample size for
future randomized trials; for a trial to have 80% power ((α= 0.05, β=0.20), and to detect
20% difference between-groups, it would require a minimum of 89 participants per
group and 178 participants in-total.

-

Rigorous randomized controlled trials are needed to define the optimal combination of
physiotherapy interventions for managing AC in patients with and without diabetes.

-

Future trials should be well-designed to minimize biases and should be reported using
CONSORT criteria [55].

-

Better reporting of standardized outcomes is needed including reliable and responsive
measures of physical activity level (RAPA) and FIT-HaNSA. Standardized
measurement instruments would improve the quality of existing research and contribute
to the ability to conduct meta-analysis in future.

-

The research team members have identified some barriers to patients’ recruitment.
Future trials should be aware of the possible challenges of conducting a large-scale
randomized trial.
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3.5 Conclusion
This randomized pilot trial established that conducting a large-scale study to assess the effect
of physiotherapy program for managing AC is feasible. However, the effect of adding
progressive walking program to PT exercises was not tested for patients with diabetes due
to the stratified randomization with this small sample; all patients with diabetes were
randomized to the regular PT program group. The current findings suggest that physiotherapy
exercises may be effective in reducing pain and improving shoulder function and ROM in
patients with and without diabetes who have AC. Researchers should be aware of the
recruitment challenges and should work on minimizing performance and detection bias by
blinding study personnel and outcome assessors.
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Figure 1: Flow diagram of the pilot study
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Table 1: Clinical characteristics of patients (n = 8)
Group allocation
Variable

Number of patients
Age: mean ± SD (range) years
Sex (M:F)
Affected side (n)
Right
Left
Both
Duration of AC (months)
BMI
Diabetes (yes / no)
Diabetes duration (years)
Heart disease (n)
Hypertension (n)
Stomach ulcers (n)
Kidney disease (n)
Depression (n)
Osteoarthritis (n)
Back pain (n)

All patients
PT

PT +

6
56±8 (43 - 65)
4:2

2
61±4 (59- 64)
1:1

8
57±8 (43- 65)
5:3

1
5

1

2
5
1
14±23 (2 -72)
24±5 (18 - 30)
3:5
-2
3
1
1
1
3
4

17±27 (2 - 72)
26±4 (18 - 30)
3:3
5±7 (6 - 17)
1
3
1
1
1
3
3

1
6±1 (5- 7)
21±4 (18- 23)
0:2
-1
-----1

PT: regular physiotherapy group, PT+: regular physiotherapy plus walking program, n: number, SD: standard
deviation, M: male, F: female, AC: adhesive capsulitis, BMI: body mass index.
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Table 2: Descriptive analysis of outcome measures for PT and PT+ groups
Baseline
(Mean ± SD)

Outcome

At three weeks
(Mean ± SD)

At six weeks
(Mean ± SD)

PT
(n= 6)

PT+
(n = 2)

All
patients

PT
(n = 2)

PT+
(n = 2)

All
patients

PT
(n = 2)

PT+
(n = 2)

FIT-HaNSA (Seconds)
Task 1
Task 2
Task 3
Tasks average
SPADI (Pain %)
SPADI (Function %)
SPADI (Total %)
RAPA
AROM (Flexion- degrees)

151±89
88±56
125±60
121±68
69±16
56±19
61±16
6±2
102±31

300±0
237±89
177±4
238±47
61±4
61±4
62±4
5±2
125±14

189±102
124±90
151±74
155±89
67±14
57±16
61±13
8±1
107±29

----

----

----

60±26
50±28
54±27
6±2
104±19

64±6
54±6
58±6
6±1
130±14

61±22
51±24
55±23
6±2
111±21

163±71
124±97
189±87
159±85
54±25
40±28
45±26
6±2
107±13

AROM (Abduction- degrees)

68±10

95±7

75±15

78±8

87±25

81±12

82±19

99±1

AROM (External rotationdegrees)
Muscle strength (Shoulder
flexors- kg)
Muscle strength (Shoulder
abductors- kg)

24±6

39±13

28±10

33±14

47±9

37±14

35±8

10±4

11±3

10±4

10±5

12±5

11±5

8±4

12±1

9±4

9±6

11±3

10±5

At 12 weeks
(Mean ± SD)
All
patients

PT
(n = 6)

PT+
(n = 1)

All
patients

----

----

----

38±30
23±29
30±28
6±2
116±14

64
73
69
8
100

42±29
30±32
35±29
6±2
114±14

86±18

95±24

70

91±24

47±2

38±9

45±11

20

41±14

11±5

11±3

11±4

13±5

8

12±5

11±4

11±1

10±4

12±5

5

11±5

243±81 183±77
212±125 146±103
276±34 211±85
244±80 180±88
45±10
52±22
35±8
38±24
39±1
44±22
7±1
6±2
128±11 112±15

FIT-HaNSA: Functional Impairment Test - Hand and Neck/ Shoulder/Arm, PT: regular physiotherapy group, PT+: regular physiotherapy plus walking program, SD:
standard deviation, SPADI: shoulder pain and disability index, RAPA: rapid assessment of physical activity questionnaire, AROM: active range of motion.
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Table 3: Description of groups physical activity level
Week/ Variable

Week 1 (PT: n = 6;
PT+: n = 1)
Week 2 (PT: n= 6;
PT+: n = 2)
Week 3 (PT: n= 6;
PT+: n = 2)
Week 4 (PT: n= 5;
PT+: n = 2)
Week 5 (PT: n= 5;
PT+: n = 2)
Week 6 (PT: n= 4;
PT+: n = 2)
Total

Fitbit (steps) (Mean ± SD)

Fitbit (distance -km) (Mean ± SD)

Walking program (n=2)
Time (minutes)
N1
N2

PT

PT+

All

PT

PT+

All

4861±2674

8199

4670±3168

3.6±2.2

5.6

3.5±2.5

40

55

5476±2247

4919±3773

5337±2389

4.3±1.7

5.5±0.1

4.6±1.5

40

45

4208±1963

7302±1514

4981±2266

3.5±2.3

5.2±1.1

3.9±2.1

40

29

5695±2057

7854±382

9850±10319

4.2±2.0

6.0±0.3

4.0±2.2

60

42

4501±1781

7224±249

5279±1972

3.5±1.4

5.1±0.2

3.9±1.4

0

30

4556±3342

7846±53

5652±3096

3.8±3.1

6.1±0.8

4.6±2.7

0

50

4883±2344

7224±1194

5962±3868

3.8±2.1

5.6±0.5

4.1±2.1

180

251

PT: regular physiotherapy group, PT+: regular physiotherapy plus walking program, SD: standard deviation.
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Table 4: A comparison of outcome measures between patients with and without diabetes

Variable

Clinical characteristics:
Age
Sex (M:F)
BMI
AC duration
FIT-HaNSA (seconds)
Task 1
Task 2
Task 3
SPADI (Pain)
SPADI (Function)
SPADI (Total)
RAPA
AROM (Flexion)
AROM (Abduction)
AROM (External
rotation)
Muscle strength
(Shoulder flexors)
Muscle strength
(Shoulder abductors)

Baseline
(Mean ± SD)

At three weeks
(Mean ± SD)

At six weeks
(Mean ± SD)

At 12 weeks
(Mean ± SD)

Diabetes
(n = 3)

No diabetes
(n = 5)

Diabetes
(n = 3)

No diabetes
(n = 5)

Diabetes
(n = 3)

No diabetes
(n = 5)

Diabetes
(n = 3)

No diabetes
(n = 4)

53±11
2:1
24±6
29±38

61±4
3:2
25±4
6±2

-----

-----

-----

-----

-----

-----

112±31
79±47
97±35
77±10
67±1
71±4
5±2
83±38
65±5
23±7

234±103
152±103
183±74
61±13
52±19
55±14
6±2
122±8
81±17
31±11

---71±11
61±5
65±4
6±3
92±20
77±7
27±6

---56±26
45±29
49±28
6±2
122±11
83±15
43±14

136 ±16
92 ±58
184 ±101
67±6
47±16
55±12
6±2
97±3
73±3
30±10

211 ±87
178 ±116
226 ±81
43±23
33±28
37±25
6±2
121±11
94±19
43±4

---31±26
12 ±10
19 ±16
7 ±2
118 ±16
100 ±26
45 ±17

---50 ±32
44 ±38
48 ±33
6 ±2
110 ±14
85 ±23
39 ±13

10±1

10±5

10±4

11±5

11±5

11±4

14 ±4

11 ±6

6±2

10±4

6±4

12±5

10±4

10±4

12 ±3

11 ±7

M: male, F: female, AC: adhesive capsulitis, FIT-HaNSA: Functional Impairment Test - Hand and Neck/ Shoulder/Arm, SD: standard deviation, SPADI: shoulder pain and
disability index, RAPA: rapid assessment of physical activity questionnaire, AROM: active range of motion
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Table 5: A comparison of physical activity level of patients with and without diabetes
Fitbit (steps) (Mean ± SD)
Week/ Variable
Week 1 (diabetes: n=
3; no diabetes: n= 5)
Week 2 (diabetes: n=
3; no diabetes: n= 5)
Week 3 (diabetes: n=
3; no diabetes: n= 5)
Week 4 (diabetes: n=
3; no diabetes: n= 4)
Week 5 (diabetes: n=
3; no diabetes: n= 4)
Week 6 (diabetes: n=
3; no diabetes: n= 3)
Total

Fitbit (distance -km) (Mean ±
SD)
Diabetes
No-diabetes
4.0±3.0
3.1±2.4

Diabetes
5320±3547

No-diabetes
4280±3280

5577±3191

5193±2198

4.0±2.4

5.0±0.8

3645±2874

5783±1647

3.4±3.5

4.2±1.1

4708±2267

6435±1825

3.2±2.6

4.9±1.4

4830±2365

5616±1922

3.8±1.8

4.0±1.3

4595±4092

6710±1967

3.9±3.8

5.2±1.6

4779±3056

5670±2140

3.7±2.9

4.4±1.4

SD: standard deviation

82

CHAPTER 4:

DOES DIABETES AFFECT FUNCTIONAL OUTCOMES
AFTER SHOULDER ARTHROPLASTY?

A form of this manuscript is published in the Journal of Clinical Orthopaedics and
Trauma

Citation:

Alsubheen, S. A., MacDermid, J. C., Overend, T. J., & Faber, K. J. (2019). Does diabetes
affect functional outcomes after shoulder arthroplasty? Journal of Clinical Orthopaedics and
Trauma, 10(3), 544-549.

83

Abstract
Objectives: The purpose of this study was to assess whether diabetes affects functional and
physical outcomes following shoulder arthroplasty.
Methods: A cohort of 140 patients were tested preoperatively, at an early follow-up visit
(between 3-6 months) and at late follow-up visit (between 1-3 years) following shoulder
arthroplasty. The American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder
Assessment Form measured shoulder pain and function and the Short-Form-12 (SF-12)
measured physical health status. Shoulder goniometry and dynamometry were used to assess
motion and strength. Diabetic status was self-reported.
Results: There were significant improvements in function and physical health status for both
patients with diabetes and patients without diabetes at the late follow-up visit. For patients with
diabetes, shoulder function (ASES: 0-30) improved from 5 (5) to 18 (6) scores (p < 0.001) and
physical health status improved from 27 (6) to 38 (8) scores (p < 0.001). For patients without
diabetes, shoulder function improved from 8 (5) to 19 (8) scores (p < 0.001) and physical health
status improved from 31 (8) to 40 (12) scores (p < 0.001). No significant differences between
patients with diabetes and patients without diabetes was detected at the late follow-up session.
Conclusion: Patients with diabetes achieve large clinical benefits from shoulder arthroplasty
that are similar to outcomes observed in patients without diabetes. Future prospective studies
with a larger sample size of patients with diabetes are needed to confirm the results of this
study.
Level of evidence: III

Keywords: Diabetes, Function, Muscle strength, Physical health status, Range of motion,
Shoulder arthroplasty
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4.1 Introduction
Shoulder arthroplasty surgery replaces the damaged humeral head and glenoid with prosthetic
implants. This surgical procedure has been shown to significantly reduce pain, restore joint
function and improve shoulder range of motion (ROM) at 2 years and beyond in patients who
underwent total shoulder arthroplasty (TSA) or hemiarthroplasty (HA)

[1–4]

. Osteoarthritis is

the primary diagnosis for 77% of shoulder arthroplasty and often occurs in middle-aged or
older adults. Hence, comorbid health problem can be prevalent; including hypertension and
diabetes which have been reported in in 63% and 20%, respectively [5].
Diabetes has been shown to be an independent risk factor for increased non-home discharge
and longer hospital stays following shoulder arthroplasty

[6,7]

. Further, diabetes, along with

hypertension and obesity, are reported to predict increased postoperative complications such
as humeral fracture and joint infection [8]. Previous research found weak associations between
patient satisfaction, physical impairment and patient-reported functional outcomes in patients
who have undergone arthroplasty

[9]

. This may reflect the diversity in presentation, patient

priorities and expectations. While it is known that diabetes is associated with poor outcomes
in ROM and patient-reported function after total knee arthroplasty [10], it is unknown whether
this is also true for shoulder arthroplasty.
The prevalence of diabetes is increasing (from 11% in 2010 to 14% by 2030)
negative impact of hyperglycemia on body tissue

[12]

postoperative complications and length of hospital stays

[11]

and the

may have an adverse effect on
[7,8]

. There is a need to investigate

whether diabetes affects functional outcomes and motion after shoulder arthroplasty. The
purpose of this study was to investigate the impact of diabetes on pain, patient-reported
function, physical health status, and impairments in shoulder ROM and muscle strength in
patients who underwent shoulder arthroplasty.

4.2 Materials and Methods
4.2.1 Study design and patients
A retrospective analysis of a prospective cohort of 140 patients undergoing shoulder
arthroplasty at an upper extremity surgical unit was conducted. Patients' demographic
characteristics were collected and recorded into a computerized database before the surgical
intervention (Baseline), and at the time of early follow-up visit (3-6 months), and again at the
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time of their late follow-up visit (1-3 years). Shoulder pain, function, ROM, muscle strength,
and physical health status were examined across these three time-points. In this study, patients
were classified into two groups: patients with diabetes and patients without diabetes based on
self-report using the Self-Administered Comorbidity Questionnaire (SCQ) which is an efficient
method to classify comorbidity that corresponds with medical record abstraction

[13]

. This

cohort included patients who were treated with a mix of surgical interventions such as TSA,
HA, and reverse TSA (rTSA). The local Research Ethics Board (REB) approved the study and
written consents were obtained from all patients before the study.

4.2.2 Outcome measures
4.2.2.1 Primary outcome
The primary outcome measure of shoulder was pain and function assessed using the American
Shoulder and Elbow Surgery (ASES) Standardized Shoulder Assessment Form [14]. The ASES
has been shown to be a valid and responsive measure of shoulder pain and function after
shoulder arthroplasty [15]. A full description of this form is published [14]. The minimal clinically
important difference (MCID) value for shoulder pain on the Visual Analogue Scale (VAS: 010) is a decrease of 1.6 points and for the 100-point ASES scale is an increase of 13.6 points.[16]
In this study, information from patients' self-evaluation [pain severity (VAS: 0-10) and
activities of daily living (0-30 scores per side)] was collected. ASES scores were compared to
norms established in an age-matched controls [17].

4.2.2.2 Secondary outcomes
The secondary outcomes included ROM, muscle strength and physical health status.
Physical health status was assessed using the Physical Component Summary (PCS) of the Short
Form-12 (SF-12) survey [18]. The SF-12 has been shown to be a valid and reliable assessment
tool [18] and has been used to assess patients after shoulder arthroplasty

[19]

. The MCID is 4.5

points for the PCS on the SF-12 survey [20].
Shoulder ROM was assessed in flexion, abduction, and external and internal rotation using a
standard goniometer. Shoulder ROM was measured using standardized procedures with known
high reliability (Intraclass Correlation Coefficients (ICCs) > 0.97) [21–23]. The MCID values for
shoulder active forward flexion is 12, active abduction is 7, and active external rotation is 3
[16]

.
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Isometric shoulder flexion, abduction, external rotation and internal rotation muscle strength
was assessed with the JTech PowerTrack handheld dynamometer (JTech; JTech Medical, Salt
Lake City, UT, USA) [concurrent validity

[24]

and reliability (ICCs 0.89-0.98)]

[25]

. Shoulder

muscle strength and ROM scores were compared to norms established in an age-matched
controls and with similar testing procedures [26,27].

4.2.3 Inclusion and exclusion criteria
Patients were included if they completed the SCQ to identify the presence of diabetes; the
ASES and/or the SF-12 questionnaires; and if their shoulder muscle strength and ROM were
measured at baseline, at early follow-up and at late follow-up visits. Exclusion criteria
included inability or refusal to complete tests/measures.

4.2.4 Statistical analysis
Statistical analyses were performed using SPSS, version 23 (SPSS Inc., Chicago, IL, USA).
Descriptive statistics were performed to evaluate normality using a Kolmogorov-Smirnov (KS) test. Descriptive statistics were calculated for the patients' demographics, and for each
outcome measure at each time point. Continuous measures were reported as means and
standard deviations and categorical measures were reported as numbers and percentages. In
bivariate analysis, patients with and without diabetes groups were compared using independent
sample t-test for continuous data (age and all outcomes measures at baseline) and Chi-square
test for categorical data. A General Linear Model (GLM) with repeated measures was used to
assess significant differences in the primary and secondary measures over time, and between
patients with and without diabetes at baseline, at early follow-up and at late follow-up visits
while controlling for the type of surgery (total arthroplasty, reverse total arthroplasty, and
hemiarthroplasty) and the indication for surgery. Mauchly’s test was used to assess the
assumption of sphericity. When sphericity was violated, degrees of freedom (df) were corrected
using Huynh-Feldt estimates of sphericity

[28]

. To assess the effectiveness of the surgical

intervention, we calculated the between group effect sizes by reporting the Standardized
Response Mean (SRM) = δᵪ / SDδᵪ. The δᵪ is the mean between-group differences, and the
SDδᵪ is the pooled standard deviation reflecting the variability of change between the two
groups. To allow and facilitate clinical decision making, benchmark values of trivial (< 0.20),
small (≥ 0.20 to < 0.50), moderate (≥ 0.50 to < 0.80) or large (≥ 0.80), proposed by Cohen,

87

were utilized

. An alpha level () of 0.05 was used to indicate statistical significance.

[29]

Significant interactions were followed by pairwise comparisons using a Bonferroni correction.

4.3 Results
4.3.1 Descriptive statistics
Patients who underwent shoulder arthroplasty and met the inclusion criteria were included in
the analysis of ASES (n=140), SF-12 (n=103), shoulder ROM (n=140), and shoulder muscle
strength (n=127). The demographic characteristics of patients who completed one or both
surveys are summarized in Table 1 and the demographic characteristics of patients whose
shoulder ROM and muscle strength were measured are summarized in Table 2. No significant
differences between patients with and without diabetes were observed for age, sex, affected
side, reason for surgery, and the type of surgical intervention. Within this cohort, 55% of the
patients were treated with total shoulder arthroplasty, 30% of the patients were treated with
reverse total shoulder arthroplasty, and 15 % of the patients were treated with hemiarthroplasty.
The main reason for surgery was joint arthritis (73%) while other reasons included shoulder
fractures, dislocation and rotator cuff arthropathy (27%). Patients were tested at baseline (preoperative), and at two time-point post-surgery: at the early follow-up visit (3-6 months), and
again at the late follow-up visit (1-3 years).

4.3.2 Effect of surgical interventions
4.3.2.1 Primary outcome
Table 3 presents the means and SD of the responses for the ASES pain and function scores at
each point in time. There was significant improvement over time (from baseline to late followup visit) on pain scores (VAS: 0-10) for patients with diabetes [7 (3.3) to 2 (2.4), p < 0.001],
and for patients without diabetes [6 (3.0) to 2 (2.3), p < 0.001].
Similarly, there were significant improvements over time on function scores (ASES: 0-30) of
the affected shoulder for patients with diabetes [5 (4.6) to 18 (6.3), p < 0.001] and for patients
without diabetes [7 (4.9) to 19 (7.3), p < 0.001]. Pairwise comparisons revealed a significant
improvement between each time point (p < 0.001) for the function score of the affected
shoulder, and between baseline and late follow-up visit for pain scores.
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Despite the higher pain (non-significant) and poorer function (mean difference (MD)= 3 points,
p = 0.032) of patients with diabetes at baseline, the differences between groups became
nonsignificant at the late follow-up visit (Table 3).
When we controlled for the type of surgery and indication for surgery the improvement over
time in ASES pain and function scores remained significant (p < 0.001) and the differences in
pain and function between patients with and without diabetes remained nonsignificant. In
addition, the interaction between time and type of surgery and between time and reason for
surgery were nonsignificant, indicating that surgical subgroups experienced similar patterns of
recovery.

4.3.2.2 Secondary outcomes
There was significant improvement over time, between baseline and early follow-up visit and
between baseline and late follow-up visit on the physical health status for patients with diabetes
[27 (5.7) to 38 (8.2), p < 0.001] and for patients without diabetes [31 (7.5) to 40 (11.5), p <
0.001] (Table 3). Despite the significant poorer physical health status of patients with diabetes
at baseline (MD= 4 points, p < 0.033), both groups recovered to a similar physical health status
at the late follow-up visit (Table 3).
As shown in Table 3, there was a significant improvement over time of the affected shoulder
ROM for both groups (p < 0.001). The independent sample t-test revealed significant
differences between groups at baseline in flexion (MD = 13 degrees, p < 0.02), and abduction
(MD = 11 degrees, p < 0.044). However, these differences became nonsignificant at the late
follow-up visit.
Similar to shoulder ROM, muscle strength of the affected shoulder significantly improved over
time for both groups (p < 0.001) as shown in Table 3. Despite the significantly weaker shoulder
flexors (MD = 2 kg, p < 0.013), abductors (MD = 2 kg, p < 0.001), and external (MD = 1 kg,
p < 0.009) and internal (MD = 1kg, p < 0.006) rotator muscle groups at baseline, patients with
diabetes regain similar muscle strength as patients without diabetes at the late follow-up visit.
The analysis of covariance, when the type of surgery and indication for surgery were controlled
for, revealed that the improvements over time in physical health status, ROM and muscle
strength remained significant (p < 0.001) and the differences between patients with diabetes
and patients without diabetes remained nonsignificant for physical health status, ROM and for
muscle strength. In addition, the interaction between time and type of surgery and between
time and reason for surgery were non-significant for the secondary outcome measures.
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4.4 Discussion
This study demonstrated that patients with and without diabetes have equally positive
improvements in shoulder function, ROM, strength and in physical health status following
shoulder arthroplasty, despite the small but significantly poorer function and physical health
status that patients with self-reported diabetes present with prior to surgery. In addition, the
improvements in shoulder pain, function, and ROM of the current study all reached statistical
and clinical significance with large effects size (Table 3), confirming prior studies that indicate
a large benefit to patients treated with shoulder arthroplasty. The overall improvements in
shoulder pain, function, ROM, and strength as well as physical health status were comparable
to previous studies despite the differences in sample size, outcome assessment tools, the follow
up periods, and the inclusion criteria [1–4,19]. However, none of these studies have examined a
subset of patients with diabetes for comparison.
Similar to previous research

[3,4]

, different types of surgery (TSA, HA, rTSA) were not

significantly different in terms of functional improvements following surgery. This may be
because the indications for different surgeries successfully allocates them to the type of surgery
providing the optimal outcome for that clinical presentation. However, our results differ from
one study that reported a greater shoulder ROM and less pain following TSA as compared to
hemiarthroplasty [1].
Despite the reported improvements in shoulder ROM and strength, patients with and without
diabetes had below-normal scores when compared to age-matched people with unaffected
shoulder [26,27]. The lower scores can be attributed to several factors including the quality of the
surrounding musculotendinous structures, the type of implant and fixation used, the general
health status of patients, and the presence of comorbidities

[2,4,8,30]

. Patients should be made

aware that improvement, not normality, is the expected outcome of surgery.
The clinical improvements in outcomes between patients with and without diabetes was
previously investigated following total knee arthroplasty (TKA) [10]. The TKA study included
20 patients with diabetes with a mean age of 72 years. Similar to our study, there were small
(non-significant) differences in knee ROM, muscle strength and Knee Society Score
questionnaire scores between groups at baseline. However, at one year follow-up, TKR patients
with and without diabetes had similar outcomes except for knee flexion which was significantly
less (10) in patients with diabetes

[10]

. According to the authors, the difference in the

rehabilitation program intensity explained the poorer knee flexion in patients with diabetes [10].
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Overall, our findings concur with results found in TKA, that patients with diabetes achieve
similar clinical benefits, as compared to their patients without diabetes counterparts.

4.4.1 Strength and limitations
This study provides new information on the impact of diabetes on shoulder pain, function,
ROM, strength and physical health status after shoulder arthroplasty. The data of this study
were prospectively collected using valid and reliable outcome measures; and the ASES scale
and SF-12 survey have been used to assess functional outcomes and physical health status after
shoulder arthroplasty. We evaluated a relatively large cohort of patients and used an
independent assessor to evaluate outcomes. However, several limitations of the current cohort
should be recognized. First, diabetes status was based on self-report which is subject to
reporting errors. However, the Katz self-administered comorbidity scale (SCQ) has been
validated to assess comorbid conditions in health services research and is equivalent to
extracting this information from medical records

[13]

. Diabetes is a condition that is likely

accurately self-reported because of the associated treatment requirements. Second, and
potentially more limiting was the fact that we did not have data about the type, the duration,
the treatments of diabetes, and the level of glycemic control. It is possible that negative of
effects of diabetes would be selectively present in with longer duration or poorer control.
Therefore, we cannot preclude that negative effects occur in this subgroup. Lastly, although
we controlled for the type of surgery and the indication for surgery and found no effect,
recovery could be affected by other uncontrolled factors such as the quality and type of implant
and the post-operative complications [1,2].

4.5 Conclusion
Patients with and without diabetes are expected to gain similar large clinical improvements in
shoulder function, motion, strength and physical health status following shoulder arthroplasty.
However, these improvements are not expected to reach normal values. Future large cohort
studies with larger numbers of patients with diabetes and more rigorous evaluation of diabetes
duration, type, and the level of glycemic control over a longer period of time could more
accurately estimate the prognosis of different subgroups of patients with diabetes; and whether
a dose-response relationship between glycemic control and outcomes is present.
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Table 1: Demographic characteristics of patients who underwent shoulder arthroplasty and
completed one or both of the self-reported surveys
Variable

Total number (n)
Age (years)
Sex: Male
Female
Dominant side: Right
Left
Affected side: Right
Left
Medical problems:
Heart disease
Hypertension
Lung disease
Primary osteoarthritis
Rheumatoid arthritis
Others (cancer, depression, kidney
and blood disease)
Reason for surgery:
Arthritis
Rotator cuff tear
Others (fracture, dislocation, revised
surgery)
Type of surgery:
Total arthroplasty
Reverse total arthroplasty
Hemiarthroplasty

ASES
Diabetes

SF-12
Diabetes

Yes
28 (20%)
75 (9)

No
112 (80%)
70 (11)

Yes
20 (19%)
73 (9)

No
83 (81%)
73 (8)

10 (7%)
18 (13%)
24 (17%)
4 (3%)
21 (15%)
7 (5%)

47 (34%)
65 (46%)
104 (74%)
8 (6%)
66 (47%)
46 (33%)

9 (9%)
11 (11%)
18 (18%)*
2 (2%)*
17 (17%)
3 (3%)

36 (35%)
47 (46%)
75 (74%)
7 (7%)
47 (46%)
36 (35%)

7 (5%)
18 (13%)*
6 (4%)*
24 (17%)
2 (1%)
34 (24%)

22 (16%)
36 (26%)
5 (4%)
83 (59%)
22 (16%)
116 (83%)

7 (7%)*
14 (14%)*
3 (3%)
17 (17%)
2 (2%)
26 (26%)

11 (11%)
25 (24%)
4 (4%)
55 (53%)
11 (11%)
81 (79%)

16 (13%)
3 (2%)
9 (6%)

60 (47%)
4 (3%)
48 (33%)

11 (11%)
1 (1%)
8 (8%)

51 (50%)
3 (3%)
29 (28%)

n = 26
16 (12%)
8 (6%)
2 (2%)

n = 110
63 (47%)
36 (26%)
11 (9%)

11 (11%)
6 (6%)
3 (3%)

50 (49%)
23 (23%)
9 (9%)

Independent sample t-test was used to detect difference in age (mean (SD)) between groups. Chi-square test was
used to detect differences between groups in all categorical data (reported as number and percentage).
*Significant difference between groups, p < 0.05. ASES: American Shoulder and Elbow Surgeons, SF-12: Short
Form-12 survey.
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Table 2: Demographic characteristics of patients who underwent shoulder arthroplasty and
whose shoulder motion and/or muscle strength were measured
Variable

Total number (n)
Age (years)
Sex: Male
Female
Dominant side: Right
Left
Affected side: Right
Left
Medical problems:
Heart disease
Hypertension
Lung disease
Primary osteoarthritis
Rheumatoid arthritis
Others (cancer, depression,
kidney and blood disease)
Reason for surgery:
Arthritis
Rotator cuff tear
Others (fracture, dislocation,
revised surgery)
Type of surgery:
Total arthroplasty
Reverse total arthroplasty
Hemiarthroplasty

ROM
Diabetes
Yes
27 (19%)
73 (8)

No
113 (81%)
71 (9)

Muscle strength
Diabetes
Yes
No
23 (18%)
104 (82%)
74 (9)
70 (9)

12 (9%)
15 (11%)
24 (17%)
3 (2%)
23 (16%)*
4 (3%)*

54 (39%)
59 (42%)
104 (74%)
9 (6%)
70 (50%)
43 (31%)

11 (9%)
12 (9%)
21 (17%)
2 (2%)
20 (16%)*
3 (2%)*

51 (40%)
53 (42%)
97 (76%)
7 (6%)
66 (52%)
38 (30%)

8 (6%)*
17 (12%)*
5 (4%)*
23 (16%)*
3 (2%)
32 (23%)

14 (10%)
34 (24%)
3 (2%)
62 (44%)
12 (9%)
90 (64%)

5 (4%)
16 (13%)*
4 (3%)
20 (16%)*
2 (2%)
27 (22%)

14 (11%)
35 (28%)
7 (6%)
68 (54%)
12 (9%)
89 (69%)

16 (13%)
2 (2%)
10 (8%)

60 (46%)
1 (1%)
46 (35%)

14 (14%)
1 (1%)
7 (6%)

63 (54%)
1 (1%)
40 (33%)

19 (14%)
6 (5%)
2 (1%)

65 (48%)
36 (26%)
11 (8%)

15 (12%)
6 (5%)
2 (2%)

62 (50%)
31 (25%)
9 (7%)

Independent sample t-test was used to detect difference in age (mean (SD)) between groups. Chi-square test was
used to detect differences between groups in all categorical data (reported as number and percentage).
*Significant difference between groups, p < 0.05. ROM: range of motion.
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Table 3: A comparison of changes in pain, function, ROM, and muscle strength between patients with
and without diabetes who underwent shoulder arthroplasty
Variable

Baseline

Early follow-up visit
(3-6 months)

Diabetes

Late follow-up visit
(1-3 years)

Diabetes

Effect size

Diabetes

Yes

No

Yes

No

Yes

No

ASES
Pain (0-10)
Function: Affected side (0-30)
Un-affected side (0-30)

7 (3)
5 (5)†
21 (8)

6 (3)
8 (5)
22 (8)

2 (1)*
13 (5)*
24 (5)*

2 (2)*
15 (7)*
24 (6)*

2 (2)*
18 (6)*
25 (4)*

2 (2)*
19 (8)*
25 (6)*

1.0
0.9

SF-12
Physical health status (0-100)
Mental health status (0-100)

27 (6)†
48 (13)

31 (8)
53 (11)

35 (8)*
48 (12)

39 (9)*
55 (9)

38 (8)*
53 (6)

40 (12)*
53 (10)

0.6

Shoulder ROM (degrees):
Flexion: Affected
Unaffected

85 (31)†
146 (33)

98 (24)
153 (22)

108 (18)*
156 (19)*

112 (26)*
158 (21)*

132 (28)*
156 (21)

132 (32)*
155 (22)

2.2

Abduction: Affected
Unaffected

65 (23)†
137 (39)

76 (25)
150 (26)

90 (21)*
150 (25)*

96 (28)*
152 (27)

115 (33)*
150 (32)

119 (36)*
152 (26)

0.7

External rotation: Affected
Unaffected

20 (12)
57 (21)

24 (12)
61 (21)

36 (18)*
64 (21)

36 (18)*
62 (22)

47 (16)*
70 (15)*

47 (23)*
68 (19)*

0.5

Internal rotation: Affected
Unaffected

3 (3)†
53 (19)

6 (10)
51 (16)

24 (11)*
55 (16)

27 (15)*
52 (15)

37 (14)*
60 (13)

38 (19)*
55 (19)

0.2

Shoulder muscle strength (kg):
Flexors: Affected
Unaffected

2 (1)†
5 (2)†

4 (3)
7 (5)

4 (2)*
5 (2)

5 (4)*
7 (4)

4 (2)*
5 (2)

5 (3)*
6 (3)

1.4

Abductors: Affected
Unaffected

2 (1)†
5 (2)†

4 (3)
8 (5)

4 (2)*
6 (2)

5 (3)*
8 (4)

4 (1)*
5 (2)

5 (3)*
7 (3)

1.0

External rotators: Affected
Unaffected

2 (1)†
4 (2)†

3 (1)
6 (3)

3 (2)*
5 (2)

3 (2)*
6 (2)

4 (2)*
5 (1)

4 (2)*
6 (2)

1.0

Internal rotators: Affected
Unaffected

3 (2)†
6 (2)

4 (2)
8 (7)

4 (2)
6 (2)

5 (2)
8 (4)

4 (2)*
6 (2)

6 (3)*
7 (3)

1.4

General linear modules-repeated measures were used to detect changes over time and between groups. Values are reported
as mean (SD). *significant effect of time (p < 0.05) between baseline and early follow-up visit and between baseline and
late follow-up visit. †significant mean difference between groups as detected by independent sample t-test.
ROM: Range of Motion, ASES: American Shoulder and Elbow Surgeons, SF-12: Short From-12 survey.
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Abstract
Background: Shoulder arthroplasty has been shown to improve function in patients with
advanced shoulder disease. However, the response to surgery and final outcomes are not easily
predictable. This study assessed the effect of residual pain, age, sex, diabetes, hypertension,
and depression on changes and status at one-year following arthroplasty with respect to
shoulder function and overall physical and mental health status.
Methods: A retrospective analysis of a prospective cohort of 140 patients tested preoperatively
and one-year following shoulder arthroplasty was conducted at our tertiary hospital. Pearson's
correlations and multiple regression analyses were performed to test the impact of predictors
on shoulder pain and function assessed using the American Shoulder and Elbow Surgery
(ASES) questionnaire, and on physical and mental health assessed using the Short Form-12.
Results: Pain and female sex were significant predictors of poorer function at one-year (R =
0.56, p = 0.001); and with other predictors, they explained 32% of the variability in function.
The explained variability of changes in function scores was 15% with pain being the only
significant predictor. Physical health was lower in older patients (r = -0.31, p < 0.05) and was
less predictable for physical health change scores (12%) and the physical status at one-year
(14%).
Conclusions: Residual pain is associated with poorer function status and less clinical benefit.
Female sex is not associated with less change in function which suggest that men and women
get equal benefit from the surgery. Advanced age relates to poorer physical health and to a
lesser extent physical change over the year.
Level of evidence: III
Keywords: Function, Physical health status, Shoulder arthroplasty
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5.1 Introduction
Shoulder arthroplasty is widely used to treat patients with severe arthritic changes in the joint
[1]

. This surgical procedure has been shown to be effective in reducing pain, improving shoulder

function and increasing range of motion (ROM)

[2,3]

. However, the overall improvement in

shoulder functional outcomes is not always predictable and can be influenced by several factors
[4]

. These factors were examined by several studies [2,4,5]; however, the results of these studies

have conflicted with one another. Young age was associated with better shoulder function on
constant score at one-year follow-up after hemiarthroplasty performed for patients with
proximal humeral fracture [6]. Further, the improvement of shoulder clinical scores over time
was associated with young age at the time of shoulder arthroplasty surgery but not with the
later follow-up years in patients with rheumatoid arthritis

[5]

. In contrary, advanced age was

associated with greater improvement (change) in shoulder function as demonstrated on the
Simple Shoulder Test (SST) following total shoulder arthroplasty (TSA)

[2]

. However, other

studies found no correlations between age and the improvement in shoulder function

[4,7]

.

Lastly, studies that assessed the effect of gender on the improvement in shoulder function found
that men had better post-operative function assessed using SST [4,7].
Physical health is expected to decline with age [4] and be adversely affected by comorbidities
[8]

. However, factors that influence physical health following shoulder arthroplasty have rarely

been examined. Advanced age is negatively associated with physical function (r = -.23) and
the better pre-operative physical health is associated with better post-operative physical
function (r = .4) as demonstrated on the Short Form-36 (SF-36) survey following TSA [4].
The presence of comorbidities, including diabetes and hypertension, have been shown to have
no effect on post-operative shoulder function [7,9], except for internal rotation ROM (R = -.2)
which was decreased with diabetes

[9]

. However, depression has been associated with lower

shoulder function assessed using the American Shoulder and Elbow Surgery (ASES) in 176
patients 2-year following TSA [10].
There are few studies which addressed the factors that influence postoperative functional
outcomes following shoulder arthroplasty. In addition, a number of these studies do not report
regression coefficients or explain the effect size attributable to these predictors. This makes it
difficult to determine how much these should influence decision-making. Finally,
comorbidities such as diabetes, hypertension and depression are rarely examined although they
are present in 20-60 % of patients undergoing shoulder arthroplasty [1].
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Identifying preoperative factors that are predictive of one-year outcomes could assist surgeons
and health care providers in providing patients more realistic expectations on outcomes and
may help plan postoperative pain management and rehabilitation. Therefore, the current study
was designed to address the following questions: 1) Do age, sex, diabetes, hypertension, and
depression predict patient-reported outcomes including shoulder pain and function, and
physical and mental health status one-year following shoulder arthroplasty? 2) Do these factors
predict the clinical benefits following surgery as reflected in the change of outcome scores? Is
residual pain (pain at one-year) associated with poorer functional outcomes?

5.2 Materials and methods
5.2.1 Study design and patients
A retrospective query of prospective collected data of patients who underwent shoulder
arthroplasty was conducted at a tertiary care referral hospital. Demographic data were collected
and recorded into a computerized database for 477 patients with shoulder arthroplasty. All
patients who completed the ASES (n = 140) and the SF-12 (n = 103) questionnaires at baseline
and at one-year follow-up visits and who completed a self-reported comorbidity survey (n =
140) were included in this analysis. This cohort included all patients treated with shoulder
arthroplasty regardless of the type of surgery based on a previous study[11] that showed nonsignificant differences in ASES and SF-12 scores between patients with different surgical
intervention (TSA, reverse TSA, hemiarthroplasty). Exclusion criteria included an inability or
refusal to complete tests/measures. The University Ethics board approved the protocol and
written consents was obtained from all patients.

5.2.2 Outcome measures
The dependent variables included the ASES

[12]

, which assessed shoulder pain and function,

and the SF-12 which assessed physical and mental health status [13]. Both questionnaires have
been shown to be valid and reliable self-reported assessment tools
previously used to assess patients after shoulder arthroplasty

[13,14]

and have been

[10]

. In this study, self-reported

pain severity (VAS: 0-10) and activities of daily living (maximum 30 scores) information were
obtained from the ASES. The Physical Component Summary Score (PCS) and the Mental
Component Summary Score (MCS) scores were obtained from the SF-12. A full description
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of ASES and SF-12 questionnaires has previously been published

[12,13]

. Both questionnaires

were administered preoperatively and at one-year follow-up visit. Next, scores from both
questionnaires were averaged and were compared among patients based on their age, sex, and
the presence of diabetes, hypertension, and depression (Table 1). To estimate the clinical
benefits of shoulder arthroplasty, we calculated the change in scores from baseline
(preoperative) to the one-year follow-up visit for the ASES function and SF-12 PCS.

5.2.3 Predictors (independent variables)
The predictive variables of interest included patient demographics: age and sex, and
comorbidities: diabetes, hypertension and depression. Patients with a preoperative self-report
of diabetes, hypertension, and depression were identified and were designated to the study
cohort. The prediction effect of these factors has been examined twice; first on the final scores
at one-year for ASES pain and function and for SF-12 PCS and MCS, and second on the change
of scores from baseline to one-year follow-up visit for ASES function and SF-12 PCS.

5.2.4 Statistical analysis
Statistical analyses were performed using SPSS software, version 23 (SPSS Inc., Chicago, IL,
USA). A P value of <.05 was considered statistically significant. Independent sample t-test
was used to detect differences in the ASES and the SF-12 scores between patients based on the
predictive variables: patients demographics (age and sex) and the presence of comorbidities
(diabetes, hypertension, depression). All values are reported as mean and standard deviation
(SD). Pearson's correlation coefficients (r) were calculated between the dependent and
predictive variables and between the predictive variables. The effect size of Pearson's
correlations were classified as follow: r = +/- 0.1= small effect, r = +/- 0.3 = medium effect, r
= +/- 0.5 = large effect

[15]

. Next, a multivariable enter regression analysis was performed to

examine the effect of the predictive variables on the improvement in ASES and SF-12 oneyear following shoulder arthroplasty. For ASES, pain at one-year was added to a second
multivariable enter regression model as a predictive variable to examine its effect on function.
To predict the clinical benefits of shoulder arthroplasty, we calculated the change in ASES
function and SF-12 PCS scores by subtracting scores at one-year follow-up visit from baseline
scores. Then, a multivariable enter regression analysis was performed on the change scores of
ASES function and SF-12 PCS. All the assumptions of multiple regression including the test
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of normality, heteroscedasticity, multicollinearity and linearity were examined prior to the
regression analysis.

5.3 Results
5.3.1 Descriptive statistics
Within this cohort, 140 patients completed the ASES and 103 patients completed the SF-12
survey. The average age of patients was 71 years (range, 47-89 years). 57% of patients
underwent TSA, 33% underwent reverse TSA and 10% underwent hemiarthroplasty.
Table 1 represents the influence of the patients' demographics on ASES and SF-12 scores oneyear following shoulder arthroplasty. For ASES, age was significantly different between
patients in all subgroups (p <0.05). Males and patients with depression were younger than
females and patients without depression while patients with diabetes and hypertension were
older than patients without these two conditions. Males had significantly better function
compared to females (r = -0.27, p = 0.001) (Table 2). For the SF-12, patients with depression
were younger and had worse mental health status compared to patients without depression
(Table 1).

5.3.2 Pearson's correlations
Pearson's correlation between dependent variables and predictors are summarized in Table 2.
The coefficients ranged from -0.31 to 0.20. There were significant correlations (p <0.05) with
a small effect size between ASES pain and depression, ASES function and sex, MCS and sex,
MCS and depression, and a medium effect size between PCS and age. Patients with depression
reported higher pain and worse mental health status, male patients had better shoulder function
and mental health status, and younger patients had better physical health status (Table 2).
When pain at one-year was added as a predictor to examine its effect on function, results
revealed a moderate relationship between residual pain and function (r = -0.51, p <0.001)
indicating that patients with higher pain had poorer shoulder function. In addition, there was a
negative association between the change in function scores and residual pain (r = -0.36, p
<0.001) indicating that patients who reported pain at one-year follow-up visit had less
improvement in shoulder function.
Pearson's correlations were performed to examine collinearity between predictors. For ASES
pain and function, results revealed significant correlations between diabetes and hypertension
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(r = -0.25, p < 0.002) and between age and depression (r = 0.26, p < 0.001). For SF-12 PCS
and MSC, results revealed significant correlations between diabetes and hypertension (r = 0.33, p < 0.001) and between age and depression (r = -0.34, p < 0.001). However, these
correlations are weak [15]. We concluded that there is no collinearity within our data.

5.3.3 Multivariable regression analysis
The regression model is summarized in Table 3. In predicting pain, depression was the only
significant predictor of pain (b = 1.5, SE = 0.63, t

(140)

= 2.4, p = 0.02) indicating that the

presence of depression increases pain by 1.5 units. Together, all predictors explained 6% of the
variability in pain.
For shoulder function, sex was a significant predictor of function (b = -4.2, SE = 1.3, t (140) = 3.2, p = 0.002) indicating that being a male improves shoulder function by 4.2 scores on ASES
index. All predictors explained 8% of the variability in function. When pain at one-year was
added as a predictor in the final model, results revealed that both sex and pain (b = -1.6, SE =
0.24, t (140) = -6.7, p < 0.001) were significant predictors of function. This indicated that as pain
increases by one unit, shoulder function decreases by 1.6 scores. The explained variability in
function increased to 32% with a greater contribution of pain.
In predicting the clinical benefits of shoulder arthroplasty, only residual pain was a significant
predictor of the change in function scores (b = -1.1, SE = 0.26, t (140) = -4.4, p < 0.001). This
indicated that with 1 unit increase in residual pain, the improvement of shoulder function
decreases by 1.1 scores. Together, all predictors explained 15% of the variability in the
improvement in function.
In predicting SF-12 physical and mental health status, age was a significant predictor of
physical health status (b = -0.48, SE = 0.15, t (103) = -3.3, p = 0.001). With one-year increase in
age, physical health status decreases by 0.5 scores. Depression had a trend to predict mental
health status (b = -6.1, SE = 3.2, t

(103)

= -1.9, p = 0.058). Together, all predictors explained

14% of the variance in physical health status and 10% of the variance in mental health status.
In predicting the change in PCS, none of the predictors were significant. However, there was
a trend for both age and hypertension to predict the change in PCS (p = 0.055). The explained
variability in PCS change scores was 12%.
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5.4 Discussion
This study found that residual pain at one-year after shoulder arthroplasty is associated with
poorer shoulder function. In addition, residual pain is the most significant predictor of function,
and with other predictors, it explains 32% of the variability in shoulder function one-year after
shoulder arthroplasty. Furthermore, residual pain is found to be the only predictor of
improvement in shoulder function and clinical benefits following shoulder arthroplasty.
It is well established that shoulder pain can significantly affect function and the ability to
perform activities of daily living [16] and pain relief is the primary goal of patients who undergo
shoulder arthroplasty

[17]

. However, for some patients, post-surgical pain persists 1-2 years

after shoulder arthroplasty, being most problematic for patients with fractures or osteoarthritis
[18]

. Our study found that residual pain at one-year is reported by 61% of patients who

underwent shoulder arthroplasty but is highly variable in intensity (range: 0.2 - 10, VAS scale).
In addition, higher pain is associated with worse shoulder function. Higher pain may be related
to arthritis in the contralateral shoulder or in other parts of the arm since often outcome
measures do not differentiate the location of the pain. However, it is also possible that closer
attention to pain peri-operatively and during rehabilitation could improve these outcomes.
In our study, statistically significant poorer shoulder function is associated with female sex. In
addition, although female sex is associated with lower functional scores, it is not associated
with less change in function which suggest that men and women get equal benefit from the
shoulder arthroplasty. Furthermore, women are more likely to have a negative change in mental
health following surgery in comparison to men (Table 2). We showed that pain is highly related
to poor shoulder function and, although not significant, women tend to report higher pain
(Table 1). This may explain the poorer shoulder function for women. These findings are
consistent with previous studies in which male patients had better improvement in function at
a longer follow-up periods ranged from 2 to 6 years following TSA [2,7].
In the present study, age is not a significant factor in predicting the change in shoulder scores
nor the one-year shoulder function. However, age relates significantly to physical health status,
in which younger patients had better physical health status, and to a lesser extent physical
change over the year but not to mental health.
These findings are consistent with the study of Donigan et al. (n = 106) who reported a nonsignificant correlations between age and improvement in shoulder function

[7]

. However,

advanced age was associated with significant better change in shoulder function in one study
2-year after TSA (n = 102)

[2]

and with less improvement in shoulder function at the time of
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surgery

[5]

and at one-year follow-up

[6]

after shoulder arthroplasty. Advanced age was also

associated with lower physical health status in the study of Matsen et al. [4]. In addition, Matsen
et al. [4] reported that the overall well-being of patients before TSA is strongly correlated with
the quality of the outcomes [4].
These conflicting findings might be related to the conflicting mechanisms by which age can
mediate outcomes. Advanced age is associated with lower occupational and life demands for
most people. Further, shoulder disorders and pathologies are common in older adults and are
associated with general decline in physical health and quality of life

[8,19]

. However, in our

regression analysis, we showed that age is not a significant predictor of the change in physical
health status. This may indicate that physical health status is expected to improve following
shoulder arthroplasty regardless to age. Other reasons for the conflicting conclusions among
studies may include the use of different patient-reported assessment tools, the differences in
the inclusion criteria, and the various sample sizes.
In general, comorbidities including diabetes, hypertension, and depression did not affect the
final outcome status nor the amount of improvement gained with surgery for shoulder function,
and physical and mental health status of this cohort' patients following shoulder arthroplasty.
However, depression is associated with higher levels of pain and there is a trend toward worse
mental health status (p = 0.058). Our inability to show significant correlations between function
and comorbidities is consistent with previous research
with our previous research

[11]

[7,9]

. These results are also consistent

in which we showed that patients with and without diabetes

recovered to the same functional level at one-year following shoulder arthroplasty despite
significantly worse pre-operative function in patients with diabetes. We concluded that patients
with diabetes achieve large clinical benefits from shoulder arthroplasty, with follow-up
outcomes equally positive to those without diabetes[11]. However, the non-significant
association between depression and shoulder function may be due to our low sample size of
patients with depression (n = 17). This lack of association differs with the study of Werner et
al. [10] who reported significant effect of depression on ASES scores and shoulder function in
88 patients with depression [10]. Our regression model showed a significant effect of depression
on ASES pain in which depression, with other predictors, explained 6% of the variability of
pain. However, the low percentage of the explained variability in pain might not have a clinical
importance. Werner et al. [10] did not include a subscale of ASES pain for comparison.

5.4.1 Strength and limitations
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This study provides new information about the impact of age, sex, diabetes, hypertension and
depression on shoulder pain and function, and physical and mental health status one-year
following shoulder arthroplasty. The data of this study were collected prospectively from a
large cohort of patients who underwent shoulder arthroplasty. Shoulder pain and function, and
physical and mental health status were evaluated using valid and reliable outcomes measures
which have been used previously by several studies

[4,10]

. However, this study has several

limitations. As with all regression models, a significant statistical relationship does not imply
causation. Further, in some of our models, the explained variation was small and thus the
clinical importance of statistically significant correlations must be questioned. Our data was
derived from a single specialty upper extremity program and may not be generalizable to other
clinical practices. We cannot distinguish the location of pain and thus residual pain is not
necessarily related to the operated shoulder. However, none of these limitations diminish the
value of this study which presented important information in a way that allow clinicians to
incorporate its findings into their decision-making when planning for this surgical procedure.

5.5 Conclusion
This study found that residual pain is associated with poorer shoulder function at one-year and
less clinical benefits over time. Female sex is associated with worse shoulder function at oneyear but not with less change in function over time which suggests that men and women get
equal benefit from the surgery. Comorbidities do not affect the final outcomes status and the
amount of improvement gained with surgery. Advanced age relates to poorer physical health
status and to a lesser extent physical change over the year. Lastly, patients with depression had
higher pain than patients without this condition. Identifying risk factors for poor functional
outcomes following shoulder arthroplasty can assist clinicians in counselling patients on the
expected outcome following shoulder arthroplasty.
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Table 1: Patient demographics and its influence on ASES and SF-12 one-year following shoulder arthroplasty
Patient's
demographics

Sex: Male
Female
Diabetes: Yes
No
Hypertension: Yes
No
Depression: Yes
No

ASES (n = 140)
Number of
patients (%)

Age
Mean (SD)

57 (41)
83 (59)
28 (20)
112 (80)
54 (39)
86 (61)
17 (12)
123 (88)

68 (12)*
73 (9)
75 (9)*
70 (11)
74 (8)*
69 (12)
64 (8)*
72 (11)

Pain:
(VAS:0-10)
Mean (SD)
1.5 (2)
2 (2)
2 (2)
2 (2)
2 (2)
2 (2)
3 (3)
2 (2)

SF-12 (n = 103)
Function:
(scores: 0-30)
Mean (SD)
20 (8)*
17 (7)
18 (6)
18 (8)
18 (7)
19 (7)
18 (6)
18 (8)

Number of
patients (%)

Age (years)
Mean (SD)

45 (44)
58 (56)
20 (19)
83 (81)
39 (38)
64 (62)
11 (11)
92 (89)

72 (7)
73 (8)
73 (9)
73 (8)
74 (7)
72 (8)
65 (9)*
74 (7)

PCS
(scores: 0-100)
Mean (SD)
42 (11)
38 (11)
38 (8)
40 (12)
38 (11)
41 (11)
39 (8)
40 (11)

MCS
(scores: 0-100)
Mean (SD)
55 (8)
52 (10)
53 (6)
53 (10)
51 (10)
54 (9)
48 (12)*
54 (9)

Independent sample t-test was used to detect differences between groups for each predictor (mean (SD)). *Significant difference between groups at P < 0.05. ASES:
American Shoulder and Elbow Surgeons, SF-12: Short Form-12 survey, PCS: physical component summary, MCS: mental component summary.
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Table 2: Pearson's correlations between predictors and dependent variables one year
following shoulder arthroplasty
Dependent variables

ASES:
Pain at 1-year
Function: Model 1
Demographics+ comorbidities
Function: Model 2
Demographics+ comorbidities
+ residual pain
Change in function scores
SF-12:
PCS at 1-year
Change in PCS scores
MCS at 1-year

Predictors
Age

Sex

Diabetes

Hypertension

Depression

0.1

0.11

0.01

0.06

0.2*

-0.02

-0.27*

-0.07

0.01

-0.03

-0.02
0.03

-0.27*
-0.09

0.01
0.11

-0.07
-0.01

-0.03
-0.02

-0.31*
-0.17*
0.08

-0.14
-0.17
-0.18*

-0.08
0.07
0.01

-0.14
-0.12*
-0.15

-0.03
-0.07
-0.21*

Change in scores was calculated by subtracting scores at one-year follow-up visit from baseline scores
Function Model 1 predictors: age, sex, diabetes, hypertension, and depression.
Function Model 2 predictors: pain at one-year, age, sex, diabetes, hypertension, and depression
* Significant at P <0 .05. ASES: American Shoulder and Elbow Surgeons, SF-12: Short Form-12 survey, PCS: physical
component summary, MCS: mental component summary.

113

Table 3: Regression model summary for dependent variables one year following shoulder
arthroplasty
Dependent variables

R

R2

Adj. R2

SE

F-statistics

Sig

0.25a

0.06

0.03

2.3

1.7

NS

ASES:
Pain
Function: Model 1
Demographics+ comorbidities
Function: Model 2
Demographics+ comorbidities
+ pain at one-year
Change in function

0.28 a

0.08

0.05

7.3

2.3

0.05

0.56b
0.38 b

0.32
0.15

0.28
0.11

6.3
6.8

10
3.9

0.001
0.001

SF-12:
PCS
Change in PCS
MCS

0.37 a
0.34 a
0.31 a

0.14
0.12
0.10

0.09
0.07
0.05

10.5
10
9.0

3.0
2.5
2.0

0.01
0.033
NS

Dependent variables at one-year
a
Predictors: (constant), age, sex, hypertension, diabetes, depression
b
Predictors: (constant), pain at one-year, age, sex, hypertension, diabetes, depression
Change in scores was calculated by subtracting scores at one-year follow-up visit from baseline scores
Function Model 1 predictors: age, sex, diabetes, hypertension, and depression.
Function Model 2 predictors: pain at one-year, age, sex, diabetes, hypertension, and depression
ASES: American Shoulder and Elbow Surgeons, SF-12: Short Form-12 survey, PCS: physical component
summary, MCS: mental component summary, NS: nonsignificant.
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CHAPTER 6:

GENERAL DISCUSSION AND IMPLICATIONS
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6.1 Overview of thesis findings
This thesis focuses on understanding the impact of diabetes on shoulder conditions leading to
a pilot study on a physiotherapy (PT) intervention that considers diabetes in management. This
work addresses a gap in the literature since remarkably few studies have focused on managing
adhesive capsulitis (AC) and shoulder recovery after arthroplasty in patients with diabetes.
This work is completed as a manuscript thesis where following chapter one which reviews the
relevant literature, a series of inter-related manuscripts are presented in individual chapters.
In chapter two, a systematic review synthesizes the quality and content of clinical research
addressing the effectiveness of non-surgical interventions for managing AC in patients with
diabetes. The systematic review showed that low-quality evidence suggests large effects of
joint mobilization plus exercises on AC in people with diabetes and weaker support was
available for corticosteroid and manipulation under anesthesia (MUA). This systematic review
has been published in the Archives of Physical Medicine and Rehabilitation journal.
Chapter three included a pilot study that compared the effect of a regular PT program to a
regular PT combined with a progressive walking program (PT+) in patients with and without
diabetes who have AC. This pilot trial established that conducting a large-scale study to assess
the effect of physiotherapy program for managing AC is feasible. The current findings suggest
that physiotherapy exercises may be effective in reducing pain and improving shoulder
function and range of motion (ROM) in patients with and without diabetes who have AC. The
sample size for future studies was also determined.
Chapter four is a cohort study that evaluated the impact of diabetes on shoulder pain, function,
ROM, and muscle strength outcomes as well as on physical health status following shoulder
arthroplasty. This study has been published in the Journal of Clinical Orthopedics and Trauma.
There was a significant improvement in all outcome measures for both patients with diabetes
and patients without diabetes with no significant differences between groups at 1-3 years after
surgery. We concluded that patients with diabetes achieve substantial clinical benefits from
shoulder arthroplasty, with follow-up outcomes equally positive to those without diabetes.
Chapter five is a cohort study that examined factors predicting shoulder function and clinical
benefits one-year following shoulder arthroplasty. This study has been published in the Iowa
Orthopedic Journal. We showed that residual pain (pain at one-year) and female sex were
significant predictors of poorer function at one-year and residual pain was the only significant
predictor of the explained variability of change in function scores. We concluded that residual
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pain is associated with poorer function status and fewer clinical benefits. Female sex is not
associated with less change in function which suggests that men and women get equal benefits
from surgery. Advanced age relates to poorer physical health at one-year following surgery.
Lastly, diabetes, hypertension, and depression neither affected shoulder function, nor physical
and mental health status at one-year following shoulder arthroplasty.

6.2 Key messages
6.2.1 What is already known on this subject
It has been consistently reported that people with diabetes are more frequently affected by AC
with long-lasting symptoms and poor prognosis. Further, although some of the therapeutic
interventions are effective in managing primary AC, several studies have reported higher
shoulder pain, reduced mobility, poor functional outcomes, reduced quality of life, and a
diminished response to treatment in patients with diabetes than patients without diabetes [1–3].
None of the previous systematic reviews focused on patients with diabetes or formally tested
diabetes as a source of clinical heterogeneity in response to treatment. Given the potential
differences in underlying mechanisms for patients with diabetes, it is unclear whether the
recommendations for treatment of AC can be equally applied to the subset of patients with
diabetes.
Adhesive capsulitis occurs five times more often in people with diabetes

[4]

. Exercises are

usually recommended to manage AC. However, the recovery is slow and often incomplete,
especially for patients with diabetes. Aerobic exercises improve hyperglycemia and insulin
sensitivity. Currently, no research has formally assessed the benefits of incorporating an
aerobic training program into the treatment plan of AC in patients with diabetes.
Shoulder arthroplasty has been shown to significantly reduce pain, restore joint function and
improve shoulder ROM at two years and beyond

[5]

. While it is known that diabetes is

associated with poor outcomes in ROM and patient-reported function after total knee
arthroplasty

[6]

, it is unknown whether this is also true for shoulder arthroplasty. Further, the

response to shoulder arthroplasty surgery and the outcomes are not easily predictable. Factors
such as age, gender, and the presence of comorbidities have been reported by a few studies to
influence functional outcomes following shoulder arthroplasty [5].
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6.2.2 What this thesis adds to the knowledge base
Low-quality evidence suggests large effects of joint mobilization plus exercises on adhesive
capsulitis in people with diabetes, although confidence in this conclusion is limited due to the
high risk of bias. Even weaker support was available for corticosteroid and MUA.
The pilot trial established that conducting a large-scale study to assess the effect of
physiotherapy program for managing AC is feasible. The current findings suggest that
physiotherapy exercises may be effective in reducing pain and improving shoulder function
and ROM in patients with and without diabetes who have AC. Future studies, with 80% power
(α= 0.05, β= 0.20) to detect a 20% between-group difference, would require a sample size of
89 participants per group. This will require a large hospital or several hospitals to manage.
Patients with diabetes achieve large clinical benefits from shoulder arthroplasty, with followup outcomes equally positive to those without diabetes. Future prospective studies with a larger
sample size of patients with diabetes are needed to confirm the results of this study.
Residual pain is associated with poorer function status and fewer clinical benefits. Female sex
is not associated with less change in function which suggests that men and women get equal
benefits from the surgery. Advanced age relates to poorer physical health. Diabetes,
hypertension, and depression neither affected shoulder function, nor physical and mental health
status at one-year following shoulder arthroplasty.

6.3 Limitations
Despite providing excellent insights into clinical approaches for diabetic shoulder, this thesis,
on the whole, had one inherent limitation besides specific limitations of the individual studies
included in it. We had time constraints that prevented us from recruiting enough subjects for
the pilot study to examine the impact of incorporating an aerobic exercise program into the
specific shoulder exercises for managing AC in patients with diabetes. However, we
established a groundwork for future trials to assess this effect based on the experience that we
gained from the pilot study.

6.4 Implication of thesis findings
The prevalence of diabetes among Canadian adults aged 20-79 years is expected to increase by
14% in 2030

[7]

. Patients with diabetes are more frequently affected by AC with long-lasting
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symptoms and poor prognosis. A combination of exercises, joint mobilization techniques and
steroid injection can be effective in reducing pain, improving shoulder function, and motion in
patients with diabetes.
In recent years, interest in the area of postoperative outcomes for patients following shoulder
arthroplasty has increased rapidly, due to the increased volume of shoulder arthroplasty surgery
and the improvement in prosthesis quality. Clinicians may expect the following:
* Patients with and without diabetes gain similar large improvements in shoulder function,
motion, and strength as well as physical health status after surgery;
* The presence of pain at one-year following shoulder arthroplasty may cause limitations in
shoulder function;
* The presence of comorbidities such as diabetes, hypertension, and depression may not affect
postoperative shoulder function and physical health status after the surgery.

6.5 Future research directions and recommendations
Rigorous RCTs that are designed to minimize bias and reported using the Consolidated
Standards of Reporting Trials (CONSORT ) criteria [8] are needed to determine the best nonsurgical intervention, assess the effect of surgical interventions, and examine the effect of
incorporating aerobic exercise program to the traditional physiotherapy program for managing
AC in patients with diabetes.
Future studies are encouraged to report the reliability and responsive measure of shoulder
functional performance. The use of standardized measurements, protocols, and timing would
improve the quality of existing trials and contribute to conducting meta-analysis in the future.
Considering 38% of patients refused to participate in this pilot trial, future clinical trials should
keep this ratio in mind before deciding on their sample size. A larger multicenter randomized
clinical trial or a single-centre trial with a long period can help to recruit the required number
of participants which in-turn can increase the power of any study.

6.6 Overall summary
Through this thesis, we have provided evidence-based information on the effect of different
non-surgical interventions and determined the feasibility of a full-scale randomized clinical
trial on managing AC in patients with diabetes. We examined the impact of diabetes on
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shoulder recovery, and factors predicting shoulder function at one-year following shoulder
arthroplasty.
This final chapter provided a general discussion and formulated conclusions based on the
previous research, including the most significant findings. We have also provided future
research directions and recommendations.
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